BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 365620 C[C@@H]4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C21H27F2N5OS/c1-14-3-2-6-28(13-14)16-4-7-27(8-5-16)21-26-12-19(30-21)20(29)25-11-18-17(23)9-15(22)10-24-18/h9-10,12,14,16H,2-8,11,13H2,1H3,(H,25,29) MUEUIRFXUWDRNF-UHFFFAOYSA-N 643072 US20240000767, Example 152::US12540134, Example 1 Alpha-2C adrenergic receptor Homo sapiens 54.0 US Patent 10.7270/Q25Q51XT aid1802250 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643072&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369887 C[C@@H]4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C21H27F2N5OS/c1-14-3-2-6-28(13-14)16-4-7-27(8-5-16)21-26-12-19(30-21)20(29)25-11-18-17(23)9-15(22)10-24-18/h9-10,12,14,16H,2-8,11,13H2,1H3,(H,25,29) MUEUIRFXUWDRNF-UHFFFAOYSA-N 643072 US20240000767, Example 152::US12540134, Example 1 Alpha-2C adrenergic receptor Homo sapiens 24.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643072&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369888 FC[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5OS/c22-9-14-2-1-5-29(13-14)16-3-6-28(7-4-16)21-27-12-19(31-21)20(30)26-11-18-17(24)8-15(23)10-25-18/h8,10,12,14,16H,1-7,9,11,13H2,(H,26,30) LJBFXAUXXNXJDB-UHFFFAOYSA-N 642965 US20240000767, Example 41::US12540134, Example 41 Alpha-2C adrenergic receptor Homo sapiens 130 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642965&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735080 490945387 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369889 FC[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5OS/c22-9-14-2-1-5-29(13-14)16-3-6-28(7-4-16)21-27-12-19(31-21)20(30)26-11-18-17(24)8-15(23)10-25-18/h8,10,12,14,16H,1-7,9,11,13H2,(H,26,30) LJBFXAUXXNXJDB-UHFFFAOYSA-N 642965 US20240000767, Example 41::US12540134, Example 41 Alpha-2C adrenergic receptor Homo sapiens 56.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642965&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735080 490945387 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369890 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC3(CC3)C2)c(F)c1 InChI=1S/C22H27F2N5OS/c23-15-10-17(24)18(25-11-15)12-26-20(30)19-13-27-21(31-19)28-8-2-16(3-9-28)29-7-1-4-22(14-29)5-6-22/h10-11,13,16H,1-9,12,14H2,(H,26,30) WMSFMRUUAJDNIZ-UHFFFAOYSA-N 642986 US20240000767, Example 64::2-[4-(5-Azaspiro[2.5]octan-5-yl)piperidin-1-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 64 Alpha-2C adrenergic receptor Homo sapiens 6.20 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642986 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642986&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735059 490945404 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369891 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC3(CC3)C2)c(F)c1 InChI=1S/C22H27F2N5OS/c23-15-10-17(24)18(25-11-15)12-26-20(30)19-13-27-21(31-19)28-8-2-16(3-9-28)29-7-1-4-22(14-29)5-6-22/h10-11,13,16H,1-9,12,14H2,(H,26,30) WMSFMRUUAJDNIZ-UHFFFAOYSA-N 642986 US20240000767, Example 64::2-[4-(5-Azaspiro[2.5]octan-5-yl)piperidin-1-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 64 Alpha-2C adrenergic receptor Homo sapiens 2.80 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642986 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642986&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735059 490945404 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369892 CCOC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C22H29F2N5O2S/c1-2-31-17-4-3-7-29(14-17)16-5-8-28(9-6-16)22-27-13-20(32-22)21(30)26-12-19-18(24)10-15(23)11-25-19/h10-11,13,16-17H,2-9,12,14H2,1H3,(H,26,30) OLYSADJEDIZFAA-UHFFFAOYSA-N 643044 US20240000767, Example 123::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3-ethoxy[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 123 Alpha-2C adrenergic receptor Homo sapiens 5.10 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643044&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369893 CCOC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C22H29F2N5O2S/c1-2-31-17-4-3-7-29(14-17)16-5-8-28(9-6-16)22-27-13-20(32-22)21(30)26-12-19-18(24)10-15(23)11-25-19/h10-11,13,16-17H,2-9,12,14H2,1H3,(H,26,30) OLYSADJEDIZFAA-UHFFFAOYSA-N 643044 US20240000767, Example 123::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3-ethoxy[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 123 Alpha-2C adrenergic receptor Homo sapiens 2.30 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643044&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369894 C[C@@H]4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C21H27F2N5OS/c1-14-3-2-6-28(13-14)16-4-7-27(8-5-16)21-26-12-19(30-21)20(29)25-11-18-17(23)9-15(22)10-24-18/h9-10,12,14,16H,2-8,11,13H2,1H3,(H,25,29) MUEUIRFXUWDRNF-UHFFFAOYSA-N 643072 US20240000767, Example 152::US12540134, Example 1 Alpha-2C adrenergic receptor Homo sapiens 121 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643072 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643072&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369895 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCc3ccccc3C2)c(F)c1 InChI=1S/C24H25F2N5OS/c25-18-11-20(26)21(27-12-18)13-28-23(32)22-14-29-24(33-22)30-9-6-19(7-10-30)31-8-5-16-3-1-2-4-17(16)15-31/h1-4,11-12,14,19H,5-10,13,15H2,(H,28,32) JLUACQZQDHMKGC-UHFFFAOYSA-N 642924 US20240000767, Example 2::N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[4-(3,4-dihydroisoquinolin-2(1H)-yl)piperidin-1-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 2 Alpha-2C adrenergic receptor Homo sapiens 5.20 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642924 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642924&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735205 490945350 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369896 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(CC3CC3)C2)c(F)c1 InChI=1S/C24H31F2N5OS/c25-18-11-20(26)21(27-12-18)13-28-23(32)22-14-29-24(33-22)30-8-5-19(6-9-30)31-7-1-2-17(15-31)10-16-3-4-16/h11-12,14,16-17,19H,1-10,13,15H2,(H,28,32) SJYFHRUFDMNIGL-UHFFFAOYSA-N 642929 US20240000767, Example 3::2-[3-(Cyclopropylmethyl)[1,4′-bipiperidin]-1′-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide (racemate)::US12540134, Example 3 Alpha-2C adrenergic receptor Homo sapiens 2.90 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642929 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642929&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735081 490945351 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369897 FC(F)C1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C21H25F4N5OS/c22-14-8-16(23)17(26-9-14)10-27-20(31)18-11-28-21(32-18)29-6-3-15(4-7-29)30-5-1-2-13(12-30)19(24)25/h8-9,11,13,15,19H,1-7,10,12H2,(H,27,31) VPWHKINYNYPEHV-UHFFFAOYSA-N 642930 US20240000767, Example 4::US12540134, Example 39 Alpha-2C adrenergic receptor Homo sapiens 169 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642930 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642930&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735100 490945352 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369898 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)C(F)(F)F)c(F)c1 InChI=1S/C21H24F5N5OS/c22-14-8-16(23)17(27-9-14)10-28-19(32)18-11-29-20(33-18)30-6-3-15(4-7-30)31-5-1-2-13(12-31)21(24,25)26/h8-9,11,13,15H,1-7,10,12H2,(H,28,32) HQKVTLUZNWDMMA-UHFFFAOYSA-N 642931 US20240000767, Example 5::US12540134, Example 5 Alpha-2C adrenergic receptor Homo sapiens 335 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642931 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642931&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735192 490945353 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369899 FCC1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C21H26F3N5OS/c22-9-14-2-1-5-29(13-14)16-3-6-28(7-4-16)21-27-12-19(31-21)20(30)26-11-18-17(24)8-15(23)10-25-18/h8,10,12,14,16H,1-7,9,11,13H2,(H,26,30) LJBFXAUXXNXJDB-UHFFFAOYSA-N 642932 US20240000767, Example 6::US12540134, Example 6 Alpha-2C adrenergic receptor Homo sapiens 335 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642932 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642932&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735098 490945354 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369900 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OCC2CC(F)(F)C2)c(F)c1 InChI=1S/C25H31F4N5O2S/c26-17-8-20(27)21(30-11-17)12-31-23(35)22-13-32-24(37-22)33-6-3-18(4-7-33)34-5-1-2-19(14-34)36-15-16-9-25(28,29)10-16/h8,11,13,16,18-19H,1-7,9-10,12,14-15H2,(H,31,35) CWQBAECTXGXCCG-UHFFFAOYSA-N 642933 US20240000767, Example 44::US20240000767, Example 7::US12540134, Example 44 Alpha-2C adrenergic receptor Homo sapiens 49.6 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642933 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642933&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156734992 490945355 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369901 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(C)c(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C22H29F2N5OS/c1-14-4-3-7-29(13-14)17-5-8-28(9-6-17)22-27-15(2)20(31-22)21(30)26-12-19-18(24)10-16(23)11-25-19/h10-11,14,17H,3-9,12-13H2,1-2H3,(H,26,30) DMRJFGWSEDSVGP-UHFFFAOYSA-N 642934 US20240000767, Example 8::US12540134, Example 8 Alpha-2C adrenergic receptor Homo sapiens 591 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642934 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642934&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435045 490945356 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369902 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(C(=O)NCc2ncc(F)cc2F)c(C)s1 |r| InChI=1S/C22H29F2N5OS/c1-14-4-3-7-29(13-14)17-5-8-28(9-6-17)22-27-20(15(2)31-22)21(30)26-12-19-18(24)10-16(23)11-25-19/h10-11,14,17H,3-9,12-13H2,1-2H3,(H,26,30) BCECKXJRRDBNOR-UHFFFAOYSA-N 642935 US20240000767, Example 9::US12540134, Example 9 Alpha-2C adrenergic receptor Homo sapiens 170 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642935 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642935&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 166933434 490945357 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369903 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(cs1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H27F2N5OS/c1-14-3-2-6-28(12-14)16-4-7-27(8-5-16)21-26-19(13-30-21)20(29)25-11-18-17(23)9-15(22)10-24-18/h9-10,13-14,16H,2-8,11-12H2,1H3,(H,25,29) FDEUCGVWKMJJFT-UHFFFAOYSA-N 642936 US20240000767, Example 10::US12540134, Example 10 Alpha-2C adrenergic receptor Homo sapiens 21.4 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642936 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642936&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 166933455 490945358 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369904 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(c(s1)C(=O)NCc1ncc(F)cc1F)C(F)(F)F |r| InChI=1S/C22H26F5N5OS/c1-13-3-2-6-32(12-13)15-4-7-31(8-5-15)21-30-19(22(25,26)27)18(34-21)20(33)29-11-17-16(24)9-14(23)10-28-17/h9-10,13,15H,2-8,11-12H2,1H3,(H,29,33) CAPQJLICKWEIEH-UHFFFAOYSA-N 642937 US20240000767, Example 11::US12540134, Example 11 Alpha-2C adrenergic receptor Homo sapiens 140 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642937 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642937&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435000 490945359 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369905 CCc1sc(nc1C(=O)NCc1ncc(F)cc1F)N1CCC(CC1)N1CCC[C@@H](C)C1 |r| InChI=1S/C23H31F2N5OS/c1-3-20-21(22(31)27-13-19-18(25)11-16(24)12-26-19)28-23(32-20)29-9-6-17(7-10-29)30-8-4-5-15(2)14-30/h11-12,15,17H,3-10,13-14H2,1-2H3,(H,27,31) LBYMOALJPIOZEP-UHFFFAOYSA-N 642938 US20240000767, Example 12::US12540134, Example 12 Alpha-2C adrenergic receptor Homo sapiens 107 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642938 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642938&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435010 490945360 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369906 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(co1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H27F2N5O2/c1-14-3-2-6-28(12-14)16-4-7-27(8-5-16)21-26-19(13-30-21)20(29)25-11-18-17(23)9-15(22)10-24-18/h9-10,13-14,16H,2-8,11-12H2,1H3,(H,25,29) HGMHACPFMGZVJO-UHFFFAOYSA-N 642939 US20240000767, Example 13::US12540134, Example 13 Alpha-2C adrenergic receptor Homo sapiens 209 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642939 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642939&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162434986 490945361 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369907 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(C(=O)NCc2ncc(F)cc2F)c(C)o1 |r| InChI=1S/C22H29F2N5O2/c1-14-4-3-7-29(13-14)17-5-8-28(9-6-17)22-27-20(15(2)31-22)21(30)26-12-19-18(24)10-16(23)11-25-19/h10-11,14,17H,3-9,12-13H2,1-2H3,(H,26,30) GMSHNYLBYUALQW-UHFFFAOYSA-N 642940 US20240000767, Example 14::US12540134, Example 14 Alpha-2C adrenergic receptor Homo sapiens 211 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642940 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642940&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435020 490945362 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369908 CO[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H27F2N5O2S/c1-30-16-3-2-6-28(13-16)15-4-7-27(8-5-15)21-26-12-19(31-21)20(29)25-11-18-17(23)9-14(22)10-24-18/h9-10,12,15-16H,2-8,11,13H2,1H3,(H,25,29) ACYWORCQNDVLGO-UHFFFAOYSA-N 642941 US20240000767, Example 15::N-[(3,5-difluoropyridin-2-yl)methyl]-2-[(3R)-3-methoxy[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 15 Alpha-2C adrenergic receptor Homo sapiens 1850 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642941 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642941&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735142 490945363 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369909 FC(F)OC1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C21H25F4N5O2S/c22-13-8-16(23)17(26-9-13)10-27-19(31)18-11-28-21(33-18)29-6-3-14(4-7-29)30-5-1-2-15(12-30)32-20(24)25/h8-9,11,14-15,20H,1-7,10,12H2,(H,27,31) DUGIRRRXICEDDA-UHFFFAOYSA-N 642942 US20240000767, Example 16::2-[3-(Difluoromethoxy)[1,4′-bipiperidin]-1′-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide (racemate)::US12540134, Example 16 Alpha-2C adrenergic receptor Homo sapiens 2000 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642942 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642942&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735012 490945364 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369910 CCC1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C22H29F2N5OS/c1-2-15-4-3-7-29(14-15)17-5-8-28(9-6-17)22-27-13-20(31-22)21(30)26-12-19-18(24)10-16(23)11-25-19/h10-11,13,15,17H,2-9,12,14H2,1H3,(H,26,30) LGIJTNSTRXQVAY-UHFFFAOYSA-N 642943 US20240000767, Example 17::N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3-ethyl[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide (racemate)::US12540134, Example 17 Alpha-2C adrenergic receptor Homo sapiens 26.5 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642943 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642943&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735136 490945365 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369911 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cc(ccn1)C(F)(F)F |r| InChI=1S/C22H28F3N5OS/c1-15-3-2-8-30(14-15)18-5-9-29(10-6-18)21-28-13-19(32-21)20(31)27-12-17-11-16(4-7-26-17)22(23,24)25/h4,7,11,13,15,18H,2-3,5-6,8-10,12,14H2,1H3,(H,27,31) TZYQMXYEERLMFR-UHFFFAOYSA-N 642944 US20240000767, Example 18::2-[(3R)-3-Methyl[1,4′-bipiperidin]-1′-yl]-N-{[4-(trifluoromethyl)pyridin-2-yl]methyl}-1,3-thiazole-5-carboxamide::US12540134, Example 18 Alpha-2C adrenergic receptor Homo sapiens 6800 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642944 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642944&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735111 490945366 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369912 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cccc(c1)C(F)(F)F |r| InChI=1S/C23H29F3N4OS/c1-16-4-3-9-30(15-16)19-7-10-29(11-8-19)22-28-14-20(32-22)21(31)27-13-17-5-2-6-18(12-17)23(24,25)26/h2,5-6,12,14,16,19H,3-4,7-11,13,15H2,1H3,(H,27,31) HSHITHPDUBUXHN-UHFFFAOYSA-N 642945 US20240000767, Example 19::2-[(3R)-3-Methyl[1,4′-bipiperidin]-1′-yl]-N-[3-(trifluoromethyl)benzyl]-1,3-thiazole-5-carboxamide::US12540134, Example 19 Alpha-2C adrenergic receptor Homo sapiens 690 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642945 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642945&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735013 490945367 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369913 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncccc1F |r| InChI=1S/C21H28FN5OS/c1-15-4-3-9-27(14-15)16-6-10-26(11-7-16)21-25-13-19(29-21)20(28)24-12-18-17(22)5-2-8-23-18/h2,5,8,13,15-16H,3-4,6-7,9-12,14H2,1H3,(H,24,28) ZURZCBXWPLILEE-UHFFFAOYSA-N 642946 US20240000767, Example 20::N-[(3-Fluoropyridin-2-yl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 20 Alpha-2C adrenergic receptor Homo sapiens 110 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642946 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642946&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735110 490945368 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369914 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cc(Cl)ccc1F |r| InChI=1S/C22H28ClFN4OS/c1-15-3-2-8-28(14-15)18-6-9-27(10-7-18)22-26-13-20(30-22)21(29)25-12-16-11-17(23)4-5-19(16)24/h4-5,11,13,15,18H,2-3,6-10,12,14H2,1H3,(H,25,29) HIDWMBYGJAWHPJ-UHFFFAOYSA-N 642947 US20240000767, Example 21::N-(5-Chloro-2-fluorobenzyl)-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 21 Alpha-2C adrenergic receptor Homo sapiens 7.20 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642947 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642947&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735028 490945369 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369915 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccc(cc1)C(F)(F)F |r| InChI=1S/C23H29F3N4OS/c1-16-3-2-10-30(15-16)19-8-11-29(12-9-19)22-28-14-20(32-22)21(31)27-13-17-4-6-18(7-5-17)23(24,25)26/h4-7,14,16,19H,2-3,8-13,15H2,1H3,(H,27,31) NVWNLAWPUXHHSF-UHFFFAOYSA-N 642948 US20240000767, Example 22::2-[(3R)-3-Methyl[1,4′-bipiperidin]-1′-yl]-N-[4-(trifluoromethyl)benzyl]-1,3-thiazole-5-carboxamide::US12540134, Example 22 Alpha-2C adrenergic receptor Homo sapiens 640 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642948 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642948&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735036 490945370 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369916 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(Cl)cc1F |r| InChI=1S/C21H27ClFN5OS/c1-14-3-2-6-28(13-14)16-4-7-27(8-5-16)21-26-12-19(30-21)20(29)25-11-18-17(23)9-15(22)10-24-18/h9-10,12,14,16H,2-8,11,13H2,1H3,(H,25,29) JXHPUNZMLGSEOI-UHFFFAOYSA-N 642949 US20240000767, Example 23::US12540134, Example 23 Alpha-2C adrenergic receptor Homo sapiens 17.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642949 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642949&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435040 490945371 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369917 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncccc1C |r| InChI=1S/C22H31N5OS/c1-16-5-4-10-27(15-16)18-7-11-26(12-8-18)22-25-14-20(29-22)21(28)24-13-19-17(2)6-3-9-23-19/h3,6,9,14,16,18H,4-5,7-8,10-13,15H2,1-2H3,(H,24,28) ISTGZUIALMAMEN-UHFFFAOYSA-N 642950 US20240000767, Example 24::US12540134, Example 24 Alpha-2C adrenergic receptor Homo sapiens 1060 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642950 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642950&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435049 490945372 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369918 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cc(C)ccn1 |r| InChI=1S/C22H31N5OS/c1-16-5-8-23-18(12-16)13-24-21(28)20-14-25-22(29-20)26-10-6-19(7-11-26)27-9-3-4-17(2)15-27/h5,8,12,14,17,19H,3-4,6-7,9-11,13,15H2,1-2H3,(H,24,28) IBJNTURIRJPQNJ-UHFFFAOYSA-N 642951 US20240000767, Example 25::US12540134, Example 25 Alpha-2C adrenergic receptor Homo sapiens 2400 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642951 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642951&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162434987 490945373 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369919 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncccc1Cl |r| InChI=1S/C21H28ClN5OS/c1-15-4-3-9-27(14-15)16-6-10-26(11-7-16)21-25-13-19(29-21)20(28)24-12-18-17(22)5-2-8-23-18/h2,5,8,13,15-16H,3-4,6-7,9-12,14H2,1H3,(H,24,28) AOAFEUDHGYMTNZ-UHFFFAOYSA-N 642952 US20240000767, Example 26::US12540134, Example 26 Alpha-2C adrenergic receptor Homo sapiens 280 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642952 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642952&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435027 490945374 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369920 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)N(C)Cc1ncccc1F |r| InChI=1S/C22H30FN5OS/c1-16-5-4-10-28(14-16)17-7-11-27(12-8-17)22-25-13-20(30-22)21(29)26(2)15-19-18(23)6-3-9-24-19/h3,6,9,13,16-17H,4-5,7-8,10-12,14-15H2,1-2H3 SBXDDPLHZCLGKE-UHFFFAOYSA-N 642953 US20240000767, Example 27::US12540134, Example 27 Alpha-2C adrenergic receptor Homo sapiens 310 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642953 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642953&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435034 490945375 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369921 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cccc(n1)C(F)(F)F |r| InChI=1S/C22H28F3N5OS/c1-15-4-3-9-30(14-15)17-7-10-29(11-8-17)21-27-13-18(32-21)20(31)26-12-16-5-2-6-19(28-16)22(23,24)25/h2,5-6,13,15,17H,3-4,7-12,14H2,1H3,(H,26,31) XDNRSPSDBMQREB-UHFFFAOYSA-N 642954 US20240000767, Example 28::2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-N-{[6- (trifluoromethyl)pyridin-2-yl]methyl}-1,3-thiazole-5-carboxamide::US12540134, Example 32 Alpha-2C adrenergic receptor Homo sapiens 890 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642954 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642954&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435005 490945376 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369922 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccc(Cl)cn1 |r| InChI=1S/C21H28ClN5OS/c1-15-3-2-8-27(14-15)18-6-9-26(10-7-18)21-25-13-19(29-21)20(28)24-12-17-5-4-16(22)11-23-17/h4-5,11,13,15,18H,2-3,6-10,12,14H2,1H3,(H,24,28) URPVBKRLWXQZOY-UHFFFAOYSA-N 642955 US20240000767, Example 29::2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-N-[(5-chloropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 29 Alpha-2C adrenergic receptor Homo sapiens 96.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642955 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642955&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435030 490945377 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369923 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1Cl |r| InChI=1S/C21H27ClFN5OS/c1-14-3-2-6-28(13-14)16-4-7-27(8-5-16)21-26-12-19(30-21)20(29)25-11-18-17(22)9-15(23)10-24-18/h9-10,12,14,16H,2-8,11,13H2,1H3,(H,25,29) GZISKYDRVKZMMR-UHFFFAOYSA-N 642956 US20240000767, Example 31::2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-N-[(3-chloro-5-fluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 31 Alpha-2C adrenergic receptor Homo sapiens 89.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642956 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642956&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162434993 490945378 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369924 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cccc(n1)C(F)(F)F |r| InChI=1S/C22H28F3N5OS/c1-15-4-3-9-30(14-15)17-7-10-29(11-8-17)21-27-13-18(32-21)20(31)26-12-16-5-2-6-19(28-16)22(23,24)25/h2,5-6,13,15,17H,3-4,7-12,14H2,1H3,(H,26,31) XDNRSPSDBMQREB-UHFFFAOYSA-N 642954 US20240000767, Example 28::2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-N-{[6- (trifluoromethyl)pyridin-2-yl]methyl}-1,3-thiazole-5-carboxamide::US12540134, Example 32 Alpha-2C adrenergic receptor Homo sapiens 640 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642954 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642954&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435005 490945376 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369925 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccc(Cl)cc1 |r| InChI=1S/C22H29ClN4OS/c1-16-3-2-10-27(15-16)19-8-11-26(12-9-19)22-25-14-20(29-22)21(28)24-13-17-4-6-18(23)7-5-17/h4-7,14,16,19H,2-3,8-13,15H2,1H3,(H,24,28) AOUQACQILRMDBX-UHFFFAOYSA-N 642958 US20240000767, Example 33::US12540134, Example 33 Alpha-2C adrenergic receptor Homo sapiens 15.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642958 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642958&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435007 490945380 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369926 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cc(F)ccc1Cl |r| InChI=1S/C22H28ClFN4OS/c1-15-3-2-8-28(14-15)18-6-9-27(10-7-18)22-26-13-20(30-22)21(29)25-12-16-11-17(24)4-5-19(16)23/h4-5,11,13,15,18H,2-3,6-10,12,14H2,1H3,(H,25,29) TVAPZDPIMJKMSH-UHFFFAOYSA-N 642959 US20240000767, Example 34::US12540134, Example 34 Alpha-2C adrenergic receptor Homo sapiens 640 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642959 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642959&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162434997 490945381 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369927 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccc(C)cc1 |r| InChI=1S/C23H32N4OS/c1-17-5-7-19(8-6-17)14-24-22(28)21-15-25-23(29-21)26-12-9-20(10-13-26)27-11-3-4-18(2)16-27/h5-8,15,18,20H,3-4,9-14,16H2,1-2H3,(H,24,28) WNISPQITENBJQS-UHFFFAOYSA-N 642960 US20240000767, Example 35::US12540134, Example 35 Alpha-2C adrenergic receptor Homo sapiens 1000 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642960 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642960&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162434990 490945382 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369928 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cccc(C)c1 |r| InChI=1S/C23H32N4OS/c1-17-5-3-7-19(13-17)14-24-22(28)21-15-25-23(29-21)26-11-8-20(9-12-26)27-10-4-6-18(2)16-27/h3,5,7,13,15,18,20H,4,6,8-12,14,16H2,1-2H3,(H,24,28) YCDYQJXWVJUZKL-UHFFFAOYSA-N 642961 US20240000767, Example 36::US12540134, Example 36 Alpha-2C adrenergic receptor Homo sapiens 190 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642961 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642961&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435023 490945383 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369929 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccccc1C |r| InChI=1S/C23H32N4OS/c1-17-6-5-11-27(16-17)20-9-12-26(13-10-20)23-25-15-21(29-23)22(28)24-14-19-8-4-3-7-18(19)2/h3-4,7-8,15,17,20H,5-6,9-14,16H2,1-2H3,(H,24,28) HQAOAAJOEAMTMU-UHFFFAOYSA-N 642962 US20240000767, Example 37::US12540134, Example 37 Alpha-2C adrenergic receptor Homo sapiens 200 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642962 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642962&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435028 490945384 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369930 FC(F)C1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C21H25F4N5OS/c22-14-8-16(23)17(26-9-14)10-27-20(31)18-11-28-21(32-18)29-6-3-15(4-7-29)30-5-1-2-13(12-30)19(24)25/h8-9,11,13,15,19H,1-7,10,12H2,(H,27,31) VPWHKINYNYPEHV-UHFFFAOYSA-N 642930 US20240000767, Example 4::US12540134, Example 39 Alpha-2C adrenergic receptor Homo sapiens 2340 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642930 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642930&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735100 490945352 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369931 FC(F)C1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C21H25F4N5OS/c22-14-8-16(23)17(26-9-14)10-27-20(31)18-11-28-21(32-18)29-6-3-15(4-7-29)30-5-1-2-13(12-30)19(24)25/h8-9,11,13,15,19H,1-7,10,12H2,(H,27,31) VPWHKINYNYPEHV-UHFFFAOYSA-N 642930 US20240000767, Example 4::US12540134, Example 39 Alpha-2C adrenergic receptor Homo sapiens 135 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642930 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642930&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735100 490945352 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369932 FC[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5OS/c22-9-14-2-1-5-29(13-14)16-3-6-28(7-4-16)21-27-12-19(31-21)20(30)26-11-18-17(24)8-15(23)10-25-18/h8,10,12,14,16H,1-7,9,11,13H2,(H,26,30) LJBFXAUXXNXJDB-UHFFFAOYSA-N 642965 US20240000767, Example 41::US12540134, Example 41 Alpha-2C adrenergic receptor Homo sapiens 243 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642965 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642965&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735080 490945387 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369933 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCC[C@H](C2)C(F)(F)F)c(F)c1 |r| InChI=1S/C21H24F5N5OS/c22-14-8-16(23)17(27-9-14)10-28-19(32)18-11-29-20(33-18)30-6-3-15(4-7-30)31-5-1-2-13(12-31)21(24,25)26/h8-9,11,13,15H,1-7,10,12H2,(H,28,32) HQKVTLUZNWDMMA-UHFFFAOYSA-N 642966 US20240000767, Example 43::US12540134, Example 43 Alpha-2C adrenergic receptor Homo sapiens 261 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642966 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642966&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735035 490945388 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369934 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OCC2CC(F)(F)C2)c(F)c1 InChI=1S/C25H31F4N5O2S/c26-17-8-20(27)21(30-11-17)12-31-23(35)22-13-32-24(37-22)33-6-3-18(4-7-33)34-5-1-2-19(14-34)36-15-16-9-25(28,29)10-16/h8,11,13,16,18-19H,1-7,9-10,12,14-15H2,(H,31,35) CWQBAECTXGXCCG-UHFFFAOYSA-N 642933 US20240000767, Example 44::US20240000767, Example 7::US12540134, Example 44 Alpha-2C adrenergic receptor Homo sapiens 41.2 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642933 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642933&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156734992 490945355 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369935 CC(NC(=O)c1cnc(N2CCC(N3CCC[C@@H](C)C3)CC2)s1)c1cc(F)ccc1F InChI=1S/C23H30F2N4OS/c1-15-4-3-9-29(14-15)18-7-10-28(11-8-18)23-26-13-21(31-23)22(30)27-16(2)19-12-17(24)5-6-20(19)25/h5-6,12-13,15-16,18H,3-4,7-11,14H2,1-2H3,(H,27,30) BZWXSCOJOIAPOU-UHFFFAOYSA-N 790393 N-[1-(2,5-Difluorophenyl)ethyl]-2-[(3R)-3-methyl[1,4'-bipiperidin]-1'-yl]-1,3-thiazole carboxamide (Diastereomers 1 and 2)::US12540134, Example 46 Alpha-2C adrenergic receptor Homo sapiens 8.30 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790393 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790393&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735150 528498180 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369936 CC(NC(=O)C1(N2CCC(N3CCC[C@H](C)C3)CC2)NC=CS1)c1cc(F)ccc1F InChI=1S/C23H32F2N4OS/c1-16-4-3-10-28(15-16)19-7-11-29(12-8-19)23(26-9-13-31-23)22(30)27-17(2)20-14-18(24)5-6-21(20)25/h5-6,9,13-14,16-17,19,26H,3-4,7-8,10-12,15H2,1-2H3,(H,27,30) HHYWPJUPXBYUGI-UHFFFAOYSA-N 790394 N-[1-(2,5-Difluorophenyl)ethyl]-2-[(3S)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole carboxamide::US12540134, Example 47 Alpha-2C adrenergic receptor Homo sapiens 25.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790394 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790394&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 178348126 528498181 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369937 COCC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C22H29F2N5O2S/c1-31-14-15-3-2-6-29(13-15)17-4-7-28(8-5-17)22-27-12-20(32-22)21(30)26-11-19-18(24)9-16(23)10-25-19/h9-10,12,15,17H,2-8,11,13-14H2,1H3,(H,26,30) ZGHRVPCMUPGYQM-UHFFFAOYSA-N 643021 US20240000767, Example 99::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[3-(methoxymethyl) [1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 100 Alpha-2C adrenergic receptor Homo sapiens 17.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643021&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369938 C[C@@H]1CCCN(C1)C1CCN(CC1)c1noc(n1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C20H26F2N6O2/c1-13-3-2-6-28(12-13)15-4-7-27(8-5-15)20-25-19(30-26-20)18(29)24-11-17-16(22)9-14(21)10-23-17/h9-10,13,15H,2-8,11-12H2,1H3,(H,24,29) VMFHHJCIVLAPFA-UHFFFAOYSA-N 642971 US20240000767, Example 49::N-[(3,5-Difluoropyridin-2-yl)methyl]-3-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,2,4-oxadiazole-5-carboxamide::US12540134, Example 49 Alpha-2C adrenergic receptor Homo sapiens 56.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642971 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642971&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735225 490945391 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369939 C[C@@H]1CCCN(C1)C1CCN(CC1F)c1ncc(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5OS/c1-13-3-2-5-28(11-13)18-4-6-29(12-16(18)24)21-27-10-19(31-21)20(30)26-9-17-15(23)7-14(22)8-25-17/h7-8,10,13,16,18H,2-6,9,11-12H2,1H3,(H,26,30) KTHHJXFIHKRDIP-UHFFFAOYSA-N 642972 US20240000767, Example 51::US20240000767, Example 52::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US20240000767, Example 50::US12540134, Example 52 Alpha-2C adrenergic receptor Homo sapiens 73.5 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642972&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735008 490945392 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369940 C[C@@H]1CCCN(C1)C1CCN(CC1F)c1ncc(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5OS/c1-13-3-2-5-28(11-13)18-4-6-29(12-16(18)24)21-27-10-19(31-21)20(30)26-9-17-15(23)7-14(22)8-25-17/h7-8,10,13,16,18H,2-6,9,11-12H2,1H3,(H,26,30) KTHHJXFIHKRDIP-UHFFFAOYSA-N 642972 US20240000767, Example 51::US20240000767, Example 52::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US20240000767, Example 50::US12540134, Example 52 Alpha-2C adrenergic receptor Homo sapiens 150 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642972&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735008 490945392 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369941 C[C@@H]1CCCN(C1)C1CCN(CC1F)c1ncc(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5OS/c1-13-3-2-5-28(11-13)18-4-6-29(12-16(18)24)21-27-10-19(31-21)20(30)26-9-17-15(23)7-14(22)8-25-17/h7-8,10,13,16,18H,2-6,9,11-12H2,1H3,(H,26,30) KTHHJXFIHKRDIP-UHFFFAOYSA-N 642972 US20240000767, Example 51::US20240000767, Example 52::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US20240000767, Example 50::US12540134, Example 52 Alpha-2C adrenergic receptor Homo sapiens 6.70 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642972 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642972&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735008 490945392 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369942 CC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)CC4 InChI=1S/C22H29F2N5OS/c1-15-3-2-7-28(8-4-15)17-5-9-29(10-6-17)22-27-14-20(31-22)21(30)26-13-19-18(24)11-16(23)12-25-19/h11-12,14-15,17H,2-10,13H2,1H3,(H,26,30) WIZHCLUYDUKIJF-UHFFFAOYSA-N 643025 US20240000767, Example 104::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[4-(4-methylazepan-1-yl)piperidin-1-yl]-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 105 Alpha-2C adrenergic receptor Homo sapiens 110 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643025&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369943 CC1CCCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C22H29F2N5OS/c1-15-4-2-3-7-29(14-15)17-5-8-28(9-6-17)22-27-13-20(31-22)21(30)26-12-19-18(24)10-16(23)11-25-19/h10-11,13,15,17H,2-9,12,14H2,1H3,(H,26,30) ZATNZCSUYFGJIF-UHFFFAOYSA-N 642976 US20240000767, Example 54::rac-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[4-(3-methylazepan-1-yl)piperidin-1-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 54 Alpha-2C adrenergic receptor Homo sapiens 230 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642976 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642976&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735117 490945394 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369944 CC(NC(=O)c1cnc(s1)N1CCC(CC1)N1CCC[C@@H](C)C1)c1ncc(F)cc1F |r| InChI=1S/C22H29F2N5OS/c1-14-4-3-7-29(13-14)17-5-8-28(9-6-17)22-26-12-19(31-22)21(30)27-15(2)20-18(24)10-16(23)11-25-20/h10-12,14-15,17H,3-9,13H2,1-2H3,(H,27,30) RNXTVMVVEWBMQV-UHFFFAOYSA-N 642977 US20240000767, Example 55::diamix-N-[1-(3,5-Difluoropyridin-2-yl)ethyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 55 Alpha-2C adrenergic receptor Homo sapiens 150 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642977 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642977&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735082 490945395 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369945 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(Cl)s1 |r| InChI=1S/C19H26ClN5OS2/c1-13-3-2-6-25(12-13)14-4-7-24(8-5-14)19-23-9-15(27-19)18(26)22-11-17-21-10-16(20)28-17/h9-10,13-14H,2-8,11-12H2,1H3,(H,22,26) BBDOJERGYJRGHL-UHFFFAOYSA-N 642978 US20240000767, Example 56::N-[(5-Chloro-1,3-thiazol-2-yl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 56 Alpha-2C adrenergic receptor Homo sapiens 240 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642978 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642978&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735227 490945396 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369946 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccc(F)s1 |r| InChI=1S/C20H27FN4OS2/c1-14-3-2-8-25(13-14)15-6-9-24(10-7-15)20-23-12-17(28-20)19(26)22-11-16-4-5-18(21)27-16/h4-5,12,14-15H,2-3,6-11,13H2,1H3,(H,22,26) YSVTUGUVDPKHGU-UHFFFAOYSA-N 642979 US20240000767, Example 57::N-[(5-Fluoro-2-thienyl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 57 Alpha-2C adrenergic receptor Homo sapiens 830 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642979 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642979&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735011 490945397 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369947 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccncc1 |r| InChI=1S/C21H29N5OS/c1-16-3-2-10-26(15-16)18-6-11-25(12-7-18)21-24-14-19(28-21)20(27)23-13-17-4-8-22-9-5-17/h4-5,8-9,14,16,18H,2-3,6-7,10-13,15H2,1H3,(H,23,27) GTILCGJSYNYTQF-UHFFFAOYSA-N 642980 US20240000767, Example 58::2-[(3R)-3-Methyl[1,4′-bipiperidin]-1′-yl]-N-(pyridin-4-ylmethyl)-1,3-thiazole-5-carboxamide::US12540134, Example 58 Alpha-2C adrenergic receptor Homo sapiens 870 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642980 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642980&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735079 490945398 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369948 O=C(NCc1ncc(F)cc1F)c4cnc(N3CCC(N2CCCC(COCC(F)(F)F)C2)CC3)s4 InChI=1S/C23H28F5N5O2S/c24-16-8-18(25)19(29-9-16)10-30-21(34)20-11-31-22(36-20)32-6-3-17(4-7-32)33-5-1-2-15(12-33)13-35-14-23(26,27)28/h8-9,11,15,17H,1-7,10,12-14H2,(H,30,34) MGVMZZPBXYYHDX-UHFFFAOYSA-N 643027 US20240000767, Example 106::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-{3-[(2,2,2-trifluoroethoxy)methyl][1,4′-bipiperidin]-1′-yl}-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 107 Alpha-2C adrenergic receptor Homo sapiens 11.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643027&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369949 FCC1(COCC2CCCN(C2)C2CCN(CC2)c2ncc(s2)C(=O)NCc2ncc(F)cc2F)CC1 InChI=1S/C26H34F3N5O2S/c27-16-26(5-6-26)17-36-15-18-2-1-7-34(14-18)20-3-8-33(9-4-20)25-32-13-23(37-25)24(35)31-12-22-21(29)10-19(28)11-30-22/h10-11,13,18,20H,1-9,12,14-17H2,(H,31,35) OQEMITLRNBOFFA-UHFFFAOYSA-N 642982 US20240000767, Example 60::rac-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[3-({[1-(fluoromethyl)cyclopropyl]methoxy}methyl)[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 60 Alpha-2C adrenergic receptor Homo sapiens 74.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642982 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642982&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735056 490945400 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369950 FC(F)C1(COCC2CCCN(C2)C2CCN(CC2)c2ncc(s2)C(=O)NCc2ncc(F)cc2F)CC1 InChI=1S/C26H33F4N5O2S/c27-18-10-20(28)21(31-11-18)12-32-23(36)22-13-33-25(38-22)34-8-3-19(4-9-34)35-7-1-2-17(14-35)15-37-16-26(5-6-26)24(29)30/h10-11,13,17,19,24H,1-9,12,14-16H2,(H,32,36) CEZIHEKGUUCKPT-UHFFFAOYSA-N 642983 US20240000767, Example 61::rac-2-[3-({[1-(Difluoromethyl)cyclopropyl]methoxy}methyl)[1,4′-bipiperidin]-1′-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 61 Alpha-2C adrenergic receptor Homo sapiens 87.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642983 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642983&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735093 490945401 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369951 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(COCC3(CC3)C(F)(F)F)C2)c(F)c1 InChI=1S/C26H32F5N5O2S/c27-18-10-20(28)21(32-11-18)12-33-23(37)22-13-34-24(39-22)35-8-3-19(4-9-35)36-7-1-2-17(14-36)15-38-16-25(5-6-25)26(29,30)31/h10-11,13,17,19H,1-9,12,14-16H2,(H,33,37) YWRZKCUPSMDAKX-UHFFFAOYSA-N 642984 US20240000767, Example 62::rac-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[3-({[1-(trifluoromethyl)cyclopropyl]methoxy}methyl)[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 62 Alpha-2C adrenergic receptor Homo sapiens 130 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642984 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642984&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735160 490945402 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369952 CC1(C)CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C22H29F2N5OS/c1-22(2)6-3-7-29(14-22)16-4-8-28(9-5-16)21-27-13-19(31-21)20(30)26-12-18-17(24)10-15(23)11-25-18/h10-11,13,16H,3-9,12,14H2,1-2H3,(H,26,30) GNJCQBOCMNCCGU-UHFFFAOYSA-N 642985 US20240000767, Example 63::N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3,3-dimethyl[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide::US12540134, Example 63 Alpha-2C adrenergic receptor Homo sapiens 570 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642985 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642985&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735208 490945403 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369953 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC3(CC3)C2)c(F)c1 InChI=1S/C22H27F2N5OS/c23-15-10-17(24)18(25-11-15)12-26-20(30)19-13-27-21(31-19)28-8-2-16(3-9-28)29-7-1-4-22(14-29)5-6-22/h10-11,13,16H,1-9,12,14H2,(H,26,30) WMSFMRUUAJDNIZ-UHFFFAOYSA-N 642986 US20240000767, Example 64::2-[4-(5-Azaspiro[2.5]octan-5-yl)piperidin-1-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 64 Alpha-2C adrenergic receptor Homo sapiens 1.40 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642986 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642986&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735059 490945404 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369954 O=C(NCc1ncc(F)cc1F)c5cnc(N4CCC(N2CCCC3(C2)CC3(F)F)CC4)s5 InChI=1S/C22H25F4N5OS/c23-14-8-16(24)17(27-9-14)10-28-19(32)18-11-29-20(33-18)30-6-2-15(3-7-30)31-5-1-4-21(13-31)12-22(21,25)26/h8-9,11,15H,1-7,10,12-13H2,(H,28,32) GEIIJNRSUPZTGW-UHFFFAOYSA-N 643053 US20240000767, Example 132::ent-2-[4-(1,1-Difluoro-5-azaspiro[2.5]octan-5-yl)piperidin-1-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide (enantiomer 2)::US12540134, Example 132 Alpha-2C adrenergic receptor Homo sapiens 4.50 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643053&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369955 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OCC2CCC2)c(F)c1 InChI=1S/C25H33F2N5O2S/c26-18-11-21(27)22(28-12-18)13-29-24(33)23-14-30-25(35-23)31-9-6-19(7-10-31)32-8-2-5-20(15-32)34-16-17-3-1-4-17/h11-12,14,17,19-20H,1-10,13,15-16H2,(H,29,33) JLGCDTMMQVNEKF-UHFFFAOYSA-N 50574217 CHEMBL4866383::US20240000767, Example 126::US12540134, Example 126 Alpha-2C adrenergic receptor Homo sapiens 1.50 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574217&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735188 471064362 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369956 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OCC2CC2)c(F)c1 InChI=1S/C24H31F2N5O2S/c25-17-10-20(26)21(27-11-17)12-28-23(32)22-13-29-24(34-22)30-8-5-18(6-9-30)31-7-1-2-19(14-31)33-15-16-3-4-16/h10-11,13,16,18-19H,1-9,12,14-15H2,(H,28,32) MUVLKMBCLRRGJM-UHFFFAOYSA-N 642989 US20240000767, Example 67::rac-2-[3-(Cyclopropylmethoxy)[1,4′-bipiperidin]-1′-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 67 Alpha-2C adrenergic receptor Homo sapiens 2.20 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642989 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642989&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735050 490945407 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369957 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(COC3CCC3)C2)c(F)c1 InChI=1S/C25H33F2N5O2S/c26-18-11-21(27)22(28-12-18)13-29-24(33)23-14-30-25(35-23)31-9-6-19(7-10-31)32-8-2-3-17(15-32)16-34-20-4-1-5-20/h11-12,14,17,19-20H,1-10,13,15-16H2,(H,29,33) KMNWWCLNNWZFIT-UHFFFAOYSA-N 50574215 CHEMBL4878875::US20240000767, Example 102::US12540134, Example 102 Alpha-2C adrenergic receptor Homo sapiens 4.30 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574215&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735109 471064360 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369958 O=C(NCc1ncc(F)cc1F)c5cnc(N4CCC(N3CCCC(COCC2CC2)C3)CC4)s5 InChI=1S/C25H33F2N5O2S/c26-19-10-21(27)22(28-11-19)12-29-24(33)23-13-30-25(35-23)31-8-5-20(6-9-31)32-7-1-2-18(14-32)16-34-15-17-3-4-17/h10-11,13,17-18,20H,1-9,12,14-16H2,(H,29,33) MBJKGPICTNTEBH-UHFFFAOYSA-N 643037 US20240000767, Example 116::ent-2-{3-[(Cyclopropylmethoxy)methyl][1,4′-bipiperidin]-1′-yl}-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide (enantiomer 2)::US12540134, Example 116 Alpha-2C adrenergic receptor Homo sapiens 5.50 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643037&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369959 CCOC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C22H29F2N5O2S/c1-2-31-17-4-3-7-29(14-17)16-5-8-28(9-6-16)22-27-13-20(32-22)21(30)26-12-19-18(24)10-15(23)11-25-19/h10-11,13,16-17H,2-9,12,14H2,1H3,(H,26,30) OLYSADJEDIZFAA-UHFFFAOYSA-N 643044 US20240000767, Example 123::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3-ethoxy[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 123 Alpha-2C adrenergic receptor Homo sapiens 22.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643044&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369960 C[C@@H]1CCCN(C1)C1CCCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C22H29F2N5OS/c1-15-4-2-8-29(14-15)17-5-3-7-28(9-6-17)22-27-13-20(31-22)21(30)26-12-19-18(24)10-16(23)11-25-19/h10-11,13,15,17H,2-9,12,14H2,1H3,(H,26,30) GTHWOCNZGDQEGI-UHFFFAOYSA-N 642993 US20240000767, Example 71::N-[(3,5-Difluoropyridin-2-yl)methyl]-2-{4-[(3R)-3-methylpiperidin-1-yl]azepan-1-yl}-1,3-thiazole-5-carboxamide::US12540134, Example 71 Alpha-2C adrenergic receptor Homo sapiens 100.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642993 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642993&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735029 490945411 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369961 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccc(C)nc1 |r| InChI=1S/C22H31N5OS/c1-16-4-3-9-27(15-16)19-7-10-26(11-8-19)22-25-14-20(29-22)21(28)24-13-18-6-5-17(2)23-12-18/h5-6,12,14,16,19H,3-4,7-11,13,15H2,1-2H3,(H,24,28) AJLKCJZUORVRKL-UHFFFAOYSA-N 642994 US20240000767, Example 72::2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-N-[(6-methylpyridin-3-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 72 Alpha-2C adrenergic receptor Homo sapiens 180 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642994 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642994&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735195 490945412 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369962 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccccc1 |r| InChI=1S/C22H30N4OS/c1-17-6-5-11-26(16-17)19-9-12-25(13-10-19)22-24-15-20(28-22)21(27)23-14-18-7-3-2-4-8-18/h2-4,7-8,15,17,19H,5-6,9-14,16H2,1H3,(H,23,27) DJHYQUQQPYFYIV-UHFFFAOYSA-N 642995 US20240000767, Example 73::N-Benzyl-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 73 Alpha-2C adrenergic receptor Homo sapiens 219 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642995 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642995&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735128 490945413 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369963 CC(F)CCOCC1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C25H34F3N5O2S/c1-17(26)6-10-35-16-18-3-2-7-33(15-18)20-4-8-32(9-5-20)25-31-14-23(36-25)24(34)30-13-22-21(28)11-19(27)12-29-22/h11-12,14,17-18,20H,2-10,13,15-16H2,1H3,(H,30,34) GCFWNWURVCANBF-UHFFFAOYSA-N 642996 US20240000767, Example 74::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[3-({[3-fluorobutyl]oxy}methyl)[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 74 Alpha-2C adrenergic receptor Homo sapiens 285 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642996 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642996&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735157 490945414 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369964 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(COCC3CC(F)(F)C3)C2)c(F)c1 InChI=1S/C26H33F4N5O2S/c27-19-8-21(28)22(31-11-19)12-32-24(36)23-13-33-25(38-23)34-6-3-20(4-7-34)35-5-1-2-17(14-35)15-37-16-18-9-26(29,30)10-18/h8,11,13,17-18,20H,1-7,9-10,12,14-16H2,(H,32,36) ZLUCGDNPVAGOFA-UHFFFAOYSA-N 642997 US20240000767, Example 75::rac-2-(3-{[(3,3-Difluorocyclobutyl)methoxy]methyl}[1,4′-bipiperidin]-1′-yl)-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 75 Alpha-2C adrenergic receptor Homo sapiens 345 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642997 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642997&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735201 490945415 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369965 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccncc1F |r| InChI=1S/C21H28FN5OS/c1-15-3-2-8-27(14-15)17-5-9-26(10-6-17)21-25-13-19(29-21)20(28)24-11-16-4-7-23-12-18(16)22/h4,7,12-13,15,17H,2-3,5-6,8-11,14H2,1H3,(H,24,28) SNHFCNFUGHCTCV-UHFFFAOYSA-N 642998 US20240000767, Example 76::N-[(3-Fluoropyridin-4-yl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 76 Alpha-2C adrenergic receptor Homo sapiens 400 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642998 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642998&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735077 490945416 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369966 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OCC(F)(F)F)c(F)c1 InChI=1S/C22H26F5N5O2S/c23-14-8-17(24)18(28-9-14)10-29-20(33)19-11-30-21(35-19)31-6-3-15(4-7-31)32-5-1-2-16(12-32)34-13-22(25,26)27/h8-9,11,15-16H,1-7,10,12-13H2,(H,29,33) OUQZWJCRNAPWAV-UHFFFAOYSA-N 642999 US20240000767, Example 77::rac-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[3-(2,2,2-trifluoroethoxy)[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 77 Alpha-2C adrenergic receptor Homo sapiens 640 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642999 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642999&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735137 490945417 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369967 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cnc(C)cc1C |r| InChI=1S/C23H33N5OS/c1-16-5-4-8-28(15-16)20-6-9-27(10-7-20)23-26-14-21(30-23)22(29)25-13-19-12-24-18(3)11-17(19)2/h11-12,14,16,20H,4-10,13,15H2,1-3H3,(H,25,29) MCQINDLAKRQFEZ-UHFFFAOYSA-N 643000 US20240000767, Example 78::N-[(4,6-Dimethylpyridin-3-yl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 78 Alpha-2C adrenergic receptor Homo sapiens 755 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643000 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643000&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735145 490945418 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369968 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1c(Cl)cnn1C |r| InChI=1S/C20H29ClN6OS/c1-14-4-3-7-27(13-14)15-5-8-26(9-6-15)20-23-12-18(29-20)19(28)22-11-17-16(21)10-24-25(17)2/h10,12,14-15H,3-9,11,13H2,1-2H3,(H,22,28) QYKPNLCXIDUXSW-UHFFFAOYSA-N 643001 US20240000767, Example 79::N-[(4-Chloro-1-methyl-1H-pyrazol-5-yl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 79 Alpha-2C adrenergic receptor Homo sapiens 50.3 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643001 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643001&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156734997 490945419 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369969 COc1cccc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCC[C@@H](C)C2)c1 |r| InChI=1S/C23H32N4O2S/c1-17-5-4-10-27(16-17)19-8-11-26(12-9-19)23-25-15-21(30-23)22(28)24-14-18-6-3-7-20(13-18)29-2/h3,6-7,13,15,17,19H,4-5,8-12,14,16H2,1-2H3,(H,24,28) FSNUCFVFZONFJE-UHFFFAOYSA-N 643002 US20240000767, Example 80::US12540134, Example 80 Alpha-2C adrenergic receptor Homo sapiens 90.5 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643002 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643002&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435050 490945420 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369970 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cc(F)ccc1F |r| InChI=1S/C22H28F2N4OS/c1-15-3-2-8-28(14-15)18-6-9-27(10-7-18)22-26-13-20(30-22)21(29)25-12-16-11-17(23)4-5-19(16)24/h4-5,11,13,15,18H,2-3,6-10,12,14H2,1H3,(H,25,29) YBYQOZCFIZVCBY-UHFFFAOYSA-N 642969 US20240000767, Example 81::US20240000767, Example 47::US12540134, Example 81 Alpha-2C adrenergic receptor Homo sapiens 22.2 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=642969 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=642969&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735213 490945390 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369971 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cccc(O)c1 |r| InChI=1S/C22H30N4O2S/c1-16-4-3-9-26(15-16)18-7-10-25(11-8-18)22-24-14-20(29-22)21(28)23-13-17-5-2-6-19(27)12-17/h2,5-6,12,14,16,18,27H,3-4,7-11,13,15H2,1H3,(H,23,28) QILVETLUJQJGNV-UHFFFAOYSA-N 643004 US20240000767, Example 82::US12540134, Example 82 Alpha-2C adrenergic receptor Homo sapiens 102 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643004 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643004&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735005 490945421 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369972 C[C@@H]1CCCN(C2CCN(c3ncc(C(=O)NC[C@H](C)c4ccccc4)s3)CC2)C1 InChI=1S/C24H34N4OS/c1-18-7-6-12-28(17-18)21-10-13-27(14-11-21)24-26-16-22(30-24)23(29)25-15-19(2)20-8-4-3-5-9-20/h3-5,8-9,16,18-19,21H,6-7,10-15,17H2,1-2H3,(H,25,29) KRBKPHYWWYGGES-UHFFFAOYSA-N 790429 rel-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-N-[(2R)-2-phenylpropyl]-1,3-thiazole-5-carboxamide::US12540134, Example 83 Alpha-2C adrenergic receptor Homo sapiens 98.1 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790429 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790429&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435006 528498216 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369973 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccc(F)cc1 |r| InChI=1S/C22H29FN4OS/c1-16-3-2-10-27(15-16)19-8-11-26(12-9-19)22-25-14-20(29-22)21(28)24-13-17-4-6-18(23)7-5-17/h4-7,14,16,19H,2-3,8-13,15H2,1H3,(H,24,28) YKTWDZYVZCZLJZ-UHFFFAOYSA-N 643006 US20240000767, Example 84::US12540134, Example 84 Alpha-2C adrenergic receptor Homo sapiens 65.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643006 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643006&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735209 490945423 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369974 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cccnc1 |r| InChI=1S/C21H29N5OS/c1-16-4-3-9-26(15-16)18-6-10-25(11-7-18)21-24-14-19(28-21)20(27)23-13-17-5-2-8-22-12-17/h2,5,8,12,14,16,18H,3-4,6-7,9-11,13,15H2,1H3,(H,23,27) FJRIFWQZIHYDMT-UHFFFAOYSA-N 643007 US20240000767, Example 85::US12540134, Example 85 Alpha-2C adrenergic receptor Homo sapiens 600 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643007 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643007&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735217 490945424 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369975 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cccc(F)c1 |r| InChI=1S/C22H29FN4OS/c1-16-4-3-9-27(15-16)19-7-10-26(11-8-19)22-25-14-20(29-22)21(28)24-13-17-5-2-6-18(23)12-17/h2,5-6,12,14,16,19H,3-4,7-11,13,15H2,1H3,(H,24,28) YOJNYVYHIYHFHP-UHFFFAOYSA-N 643008 US20240000767, Example 86::US12540134, Example 86 Alpha-2C adrenergic receptor Homo sapiens 28.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643008 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643008&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735047 490945425 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369976 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccccc1F |r| InChI=1S/C22H29FN4OS/c1-16-5-4-10-27(15-16)18-8-11-26(12-9-18)22-25-14-20(29-22)21(28)24-13-17-6-2-3-7-19(17)23/h2-3,6-7,14,16,18H,4-5,8-13,15H2,1H3,(H,24,28) FKJPWJGWBOAONO-UHFFFAOYSA-N 643009 US20240000767, Example 87::US12540134, Example 87 Alpha-2C adrenergic receptor Homo sapiens 25.5 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643009 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643009&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435009 490945426 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369977 C[C@@H]1CCCN(C2CCN(c3ncc(C(=O)Nc4ccc(F)cc4Cl)s3)CC2)C1 InChI=1S/C21H26ClFN4OS/c1-14-3-2-8-27(13-14)16-6-9-26(10-7-16)21-24-12-19(29-21)20(28)25-18-5-4-15(23)11-17(18)22/h4-5,11-12,14,16H,2-3,6-10,13H2,1H3,(H,25,28) YQACFKPKKNRHSS-UHFFFAOYSA-N 790434 N-(2-chloro-4-fluorophenyl)-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 88 Alpha-2C adrenergic receptor Homo sapiens 489 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790434 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790434&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435026 528498221 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369978 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)Nc1ccc(F)c(c1)C#N |r| InChI=1S/C22H26FN5OS/c1-15-3-2-8-28(14-15)18-6-9-27(10-7-18)22-25-13-20(30-22)21(29)26-17-4-5-19(23)16(11-17)12-24/h4-5,11,13,15,18H,2-3,6-10,14H2,1H3,(H,26,29) PLBKVYLOIRMHCK-UHFFFAOYSA-N 643011 US20240000767, Example 89::US12540134, Example 89 Alpha-2C adrenergic receptor Homo sapiens 230 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643011 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643011&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735165 490945428 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369979 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)N(C)Cc1cccnc1 |r| InChI=1S/C22H31N5OS/c1-17-5-4-10-27(15-17)19-7-11-26(12-8-19)22-24-14-20(29-22)21(28)25(2)16-18-6-3-9-23-13-18/h3,6,9,13-14,17,19H,4-5,7-8,10-12,15-16H2,1-2H3 ORFZQIGUARGWRV-UHFFFAOYSA-N 643012 US20240000767, Example 90::US12540134, Example 90 Alpha-2C adrenergic receptor Homo sapiens 971 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643012 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643012&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162434983 490945429 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369980 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)N(C)Cc1ccncc1 |r| InChI=1S/C22H31N5OS/c1-17-4-3-11-27(15-17)19-7-12-26(13-8-19)22-24-14-20(29-22)21(28)25(2)16-18-5-9-23-10-6-18/h5-6,9-10,14,17,19H,3-4,7-8,11-13,15-16H2,1-2H3 ITFQFYDPIGMOQJ-UHFFFAOYSA-N 643013 US20240000767, Example 91::US12540134, Example 91 Alpha-2C adrenergic receptor Homo sapiens 284 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643013 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643013&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735172 490945430 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369981 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)N(C)Cc1ccccc1 |r| InChI=1S/C23H32N4OS/c1-18-7-6-12-27(16-18)20-10-13-26(14-11-20)23-24-15-21(29-23)22(28)25(2)17-19-8-4-3-5-9-19/h3-5,8-9,15,18,20H,6-7,10-14,16-17H2,1-2H3 BKCGWYZIBKIXIK-UHFFFAOYSA-N 643014 US20240000767, Example 92::US12540134, Example 92 Alpha-2C adrenergic receptor Homo sapiens 85.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643014 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643014&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735004 490945431 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369982 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)Nc1ccccc1C1CC1 |r| InChI=1S/C24H32N4OS/c1-17-5-4-12-28(16-17)19-10-13-27(14-11-19)24-25-15-22(30-24)23(29)26-21-7-3-2-6-20(21)18-8-9-18/h2-3,6-7,15,17-19H,4-5,8-14,16H2,1H3,(H,26,29) NIYXOFSGXBPMRD-UHFFFAOYSA-N 643015 US20240000767, Example 93::US12540134, Example 93 Alpha-2C adrenergic receptor Homo sapiens 630 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643015 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643015&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735037 490945432 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369983 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1cccc(Cl)c1 |r| InChI=1S/C22H29ClN4OS/c1-16-4-3-9-27(15-16)19-7-10-26(11-8-19)22-25-14-20(29-22)21(28)24-13-17-5-2-6-18(23)12-17/h2,5-6,12,14,16,19H,3-4,7-11,13,15H2,1H3,(H,24,28) YEVQBXSCEUISLP-UHFFFAOYSA-N 643016 US20240000767, Example 94::US12540134, Example 94 Alpha-2C adrenergic receptor Homo sapiens 150 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643016 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643016&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435016 490945433 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369984 Cc1ccc([C@@H](C)NC(=O)c2cnc(N3CCC(N4CCC[C@@H](C)C4)CC3)s2)cc1 InChI=1S/C24H34N4OS/c1-17-6-8-20(9-7-17)19(3)26-23(29)22-15-25-24(30-22)27-13-10-21(11-14-27)28-12-4-5-18(2)16-28/h6-9,15,18-19,21H,4-5,10-14,16H2,1-3H3,(H,26,29) GNGRNDMCBCKQPA-UHFFFAOYSA-N 790441 rel-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-N-[(1R)-1-(4-methylphenyl)ethyl]-1,3-thiazole-5-carboxamide::US12540134, Example 95 Alpha-2C adrenergic receptor Homo sapiens 800 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790441 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790441&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435025 528498228 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369985 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)Nc1cc(Cl)ccc1O |r| InChI=1S/C21H27ClN4O2S/c1-14-3-2-8-26(13-14)16-6-9-25(10-7-16)21-23-12-19(29-21)20(28)24-17-11-15(22)4-5-18(17)27/h4-5,11-12,14,16,27H,2-3,6-10,13H2,1H3,(H,24,28) STTXTBWAQJHCME-UHFFFAOYSA-N 643018 US20240000767, Example 96::US12540134, Example 96 Alpha-2C adrenergic receptor Homo sapiens 1000 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643018 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643018&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735216 490945435 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369986 COc1ccc(F)cc1NC(=O)c1cnc(s1)N1CCC(CC1)N1CCC[C@@H](C)C1 |r| InChI=1S/C22H29FN4O2S/c1-15-4-3-9-27(14-15)17-7-10-26(11-8-17)22-24-13-20(30-22)21(28)25-18-12-16(23)5-6-19(18)29-2/h5-6,12-13,15,17H,3-4,7-11,14H2,1-2H3,(H,25,28) QPMZNVADBWYUEK-UHFFFAOYSA-N 643019 US20240000767, Example 97::US12540134, Example 97 Alpha-2C adrenergic receptor Homo sapiens 1300 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643019 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643019&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735120 490945436 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369987 CCc1cc(NC(=O)c2cnc(s2)N2CCC(CC2)N2CCC[C@@H](C)C2)ccn1 |r| InChI=1S/C22H31N5OS/c1-3-17-13-18(6-9-23-17)25-21(28)20-14-24-22(29-20)26-11-7-19(8-12-26)27-10-4-5-16(2)15-27/h6,9,13-14,16,19H,3-5,7-8,10-12,15H2,1-2H3,(H,23,25,28) IFHHKKAHCKJOEC-UHFFFAOYSA-N 643020 US20240000767, Example 98::US12540134, Example 98 Alpha-2C adrenergic receptor Homo sapiens 1600 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643020 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643020&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735140 490945437 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369988 COCC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C22H29F2N5O2S/c1-31-14-15-3-2-6-29(13-15)17-4-7-28(8-5-17)22-27-12-20(32-22)21(30)26-11-19-18(24)9-16(23)10-25-19/h9-10,12,15,17H,2-8,11,13-14H2,1H3,(H,26,30) ZGHRVPCMUPGYQM-UHFFFAOYSA-N 643021 US20240000767, Example 99::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[3-(methoxymethyl) [1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 100 Alpha-2C adrenergic receptor Homo sapiens 590 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643021&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369989 COCC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C22H29F2N5O2S/c1-31-14-15-3-2-6-29(13-15)17-4-7-28(8-5-17)22-27-12-20(32-22)21(30)26-11-19-18(24)9-16(23)10-25-19/h9-10,12,15,17H,2-8,11,13-14H2,1H3,(H,26,30) ZGHRVPCMUPGYQM-UHFFFAOYSA-N 643021 US20240000767, Example 99::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[3-(methoxymethyl) [1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 100 Alpha-2C adrenergic receptor Homo sapiens 2.90 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643021 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643021&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369990 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(COC3CCC3)C2)c(F)c1 InChI=1S/C25H33F2N5O2S/c26-18-11-21(27)22(28-12-18)13-29-24(33)23-14-30-25(35-23)31-9-6-19(7-10-31)32-8-2-3-17(15-32)16-34-20-4-1-5-20/h11-12,14,17,19-20H,1-10,13,15-16H2,(H,29,33) KMNWWCLNNWZFIT-UHFFFAOYSA-N 50574215 CHEMBL4878875::US20240000767, Example 102::US12540134, Example 102 Alpha-2C adrenergic receptor Homo sapiens 2.30 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574215&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735109 471064360 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369991 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(COC3CCC3)C2)c(F)c1 InChI=1S/C25H33F2N5O2S/c26-18-11-21(27)22(28-12-18)13-29-24(33)23-14-30-25(35-23)31-9-6-19(7-10-31)32-8-2-3-17(15-32)16-34-20-4-1-5-20/h11-12,14,17,19-20H,1-10,13,15-16H2,(H,29,33) KMNWWCLNNWZFIT-UHFFFAOYSA-N 50574215 CHEMBL4878875::US20240000767, Example 102::US12540134, Example 102 Alpha-2C adrenergic receptor Homo sapiens 0.085 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574215&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735109 471064360 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369992 CC(C)C1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C23H31F2N5OS/c1-15(2)16-4-3-7-30(14-16)18-5-8-29(9-6-18)23-28-13-21(32-23)22(31)27-12-20-19(25)10-17(24)11-26-20/h10-11,13,15-16,18H,3-9,12,14H2,1-2H3,(H,27,31) QRSWMDSTVFUENC-UHFFFAOYSA-N 643024 US20240000767, Example 103::rac-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3-isopropyl[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide::US12540134, Example 103 Alpha-2C adrenergic receptor Homo sapiens 0.830 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643024 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643024&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735053 490945440 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369993 CC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)CC4 InChI=1S/C22H29F2N5OS/c1-15-3-2-7-28(8-4-15)17-5-9-29(10-6-17)22-27-14-20(31-22)21(30)26-13-19-18(24)11-16(23)12-25-19/h11-12,14-15,17H,2-10,13H2,1H3,(H,26,30) WIZHCLUYDUKIJF-UHFFFAOYSA-N 643025 US20240000767, Example 104::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[4-(4-methylazepan-1-yl)piperidin-1-yl]-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 105 Alpha-2C adrenergic receptor Homo sapiens 10.00 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643025&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369994 CC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)CC4 InChI=1S/C22H29F2N5OS/c1-15-3-2-7-28(8-4-15)17-5-9-29(10-6-17)22-27-14-20(31-22)21(30)26-13-19-18(24)11-16(23)12-25-19/h11-12,14-15,17H,2-10,13H2,1H3,(H,26,30) WIZHCLUYDUKIJF-UHFFFAOYSA-N 643025 US20240000767, Example 104::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[4-(4-methylazepan-1-yl)piperidin-1-yl]-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 105 Alpha-2C adrenergic receptor Homo sapiens 4.30 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643025 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643025&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369995 O=C(NCc1ncc(F)cc1F)c4cnc(N3CCC(N2CCCC(COCC(F)(F)F)C2)CC3)s4 InChI=1S/C23H28F5N5O2S/c24-16-8-18(25)19(29-9-16)10-30-21(34)20-11-31-22(36-20)32-6-3-17(4-7-32)33-5-1-2-15(12-33)13-35-14-23(26,27)28/h8-9,11,15,17H,1-7,10,12-14H2,(H,30,34) MGVMZZPBXYYHDX-UHFFFAOYSA-N 643027 US20240000767, Example 106::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-{3-[(2,2,2-trifluoroethoxy)methyl][1,4′-bipiperidin]-1′-yl}-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 107 Alpha-2C adrenergic receptor Homo sapiens 0.500 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643027&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369996 O=C(NCc1ncc(F)cc1F)c4cnc(N3CCC(N2CCCC(COCC(F)(F)F)C2)CC3)s4 InChI=1S/C23H28F5N5O2S/c24-16-8-18(25)19(29-9-16)10-30-21(34)20-11-31-22(36-20)32-6-3-17(4-7-32)33-5-1-2-15(12-33)13-35-14-23(26,27)28/h8-9,11,15,17H,1-7,10,12-14H2,(H,30,34) MGVMZZPBXYYHDX-UHFFFAOYSA-N 643027 US20240000767, Example 106::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-{3-[(2,2,2-trifluoroethoxy)methyl][1,4′-bipiperidin]-1′-yl}-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 107 Alpha-2C adrenergic receptor Homo sapiens 37.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643027 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643027&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369997 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OCC2CC2(F)F)c(F)c1 InChI=1S/C24H29F4N5O2S/c25-16-8-19(26)20(29-10-16)11-30-22(34)21-12-31-23(36-21)32-6-3-17(4-7-32)33-5-1-2-18(13-33)35-14-15-9-24(15,27)28/h8,10,12,15,17-18H,1-7,9,11,13-14H2,(H,30,34) YAJMPZFDYPOFQB-UHFFFAOYSA-N 50574216 CHEMBL4876214::US20240000767, Example 108::US12540134, Example 108 Alpha-2C adrenergic receptor Homo sapiens 0.370 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574216&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735115 471064361 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369998 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OC2CCC2)c(F)c1 InChI=1S/C24H31F2N5O2S/c25-16-11-20(26)21(27-12-16)13-28-23(32)22-14-29-24(34-22)30-9-6-17(7-10-30)31-8-2-5-19(15-31)33-18-3-1-4-18/h11-12,14,17-19H,1-10,13,15H2,(H,28,32) PQSFSDBBIGAKMY-UHFFFAOYSA-N 643030 US20240000767, Example 109::rac-2-[3-(Cyclobutyloxy)[1,4′-bipiperidin]-1′-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 109 Alpha-2C adrenergic receptor Homo sapiens 0.850 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643030 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643030&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735183 490945442 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 369999 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OC2CC(F)(F)C2)c(F)c1 InChI=1S/C24H29F4N5O2S/c25-15-8-19(26)20(29-11-15)12-30-22(34)21-13-31-23(36-21)32-6-3-16(4-7-32)33-5-1-2-17(14-33)35-18-9-24(27,28)10-18/h8,11,13,16-18H,1-7,9-10,12,14H2,(H,30,34) TXNAGJKGFLZIGC-UHFFFAOYSA-N 643031 US20240000767, Example 110::rac-2-{3-[(3,3-Difluorocyclobutyl)oxy][1,4′-bipiperidin]-1′-yl}-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 110 Alpha-2C adrenergic receptor Homo sapiens 1.50 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643031 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643031&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735127 490945443 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370000 C[C@@H]1CCCN(C1)C1CCN(CC1F)c1nc(cs1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5OS/c1-13-3-2-5-28(10-13)19-4-6-29(11-16(19)24)21-27-18(12-31-21)20(30)26-9-17-15(23)7-14(22)8-25-17/h7-8,12-13,16,19H,2-6,9-11H2,1H3,(H,26,30) XAKCPRDPHQCQFB-UHFFFAOYSA-N 643032 US20240000767, Example 111::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-4-carboxamide::US12540134, Example 158 Alpha-2C adrenergic receptor Homo sapiens 0.490 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643032&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735155 490945444 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370001 C[C@@H]1CCCN(C1)C1CCN(CC1F)c1nc(co1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5O2/c1-13-3-2-5-28(10-13)19-4-6-29(11-16(19)24)21-27-18(12-31-21)20(30)26-9-17-15(23)7-14(22)8-25-17/h7-8,12-13,16,19H,2-6,9-11H2,1H3,(H,26,30) IOJRZQDGTDXSAE-UHFFFAOYSA-N 643033 US20240000767, Example 112::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-oxazole-4-carboxamide::US12540134, Example 160 Alpha-2C adrenergic receptor Homo sapiens 1.20 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643033&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735087 490945445 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370002 C[C@@H]1CCCN(C2CCN(c3ncc(C(=O)NCc4cc(F)ccc4F)s3)CC2F)C1 InChI=1S/C22H27F3N4OS/c1-14-3-2-7-28(12-14)19-6-8-29(13-18(19)25)22-27-11-20(31-22)21(30)26-10-15-9-16(23)4-5-17(15)24/h4-5,9,11,14,18-19H,2-3,6-8,10,12-13H2,1H3,(H,26,30) BXSKALAMKLMMPQ-UHFFFAOYSA-N 790459 diamix-N-(5-Chloro-2-fluorobenzyl)-2-[(3R)-3'-fluoro-3-methyl[1,4'-bipiperidin]-1'-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 113 Alpha-2C adrenergic receptor Homo sapiens 0.610 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790459 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790459&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370003 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCC[C@H](C2)OCC2CC2)c(F)c1 |r| InChI=1S/C24H31F2N5O2S/c25-17-10-20(26)21(27-11-17)12-28-23(32)22-13-29-24(34-22)30-8-5-18(6-9-30)31-7-1-2-19(14-31)33-15-16-3-4-16/h10-11,13,16,18-19H,1-9,12,14-15H2,(H,28,32) MUVLKMBCLRRGJM-UHFFFAOYSA-N 643035 US20240000767, Example 114::2-[(3R)-3-(Cyclopropylmethoxy)[1,4′-bipiperidin]-1′-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 114 Alpha-2C adrenergic receptor Homo sapiens 1.30 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643035 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643035&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735107 490945447 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370004 O=C(NCc1ncc(F)cc1F)c5cnc(N4CCC(N3CCCC(COCC2CC2)C3)CC4)s5 InChI=1S/C25H33F2N5O2S/c26-19-10-21(27)22(28-11-19)12-29-24(33)23-13-30-25(35-23)31-8-5-20(6-9-31)32-7-1-2-18(14-32)16-34-15-17-3-4-17/h10-11,13,17-18,20H,1-9,12,14-16H2,(H,29,33) MBJKGPICTNTEBH-UHFFFAOYSA-N 643037 US20240000767, Example 116::ent-2-{3-[(Cyclopropylmethoxy)methyl][1,4′-bipiperidin]-1′-yl}-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide (enantiomer 2)::US12540134, Example 116 Alpha-2C adrenergic receptor Homo sapiens 0.610 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643037&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370005 O=C(NCc1ncc(F)cc1F)c5cnc(N4CCC(N3CCCC(COCC2CC2)C3)CC4)s5 InChI=1S/C25H33F2N5O2S/c26-19-10-21(27)22(28-11-19)12-29-24(33)23-13-30-25(35-23)31-8-5-20(6-9-31)32-7-1-2-18(14-32)16-34-15-17-3-4-17/h10-11,13,17-18,20H,1-9,12,14-16H2,(H,29,33) MBJKGPICTNTEBH-UHFFFAOYSA-N 643037 US20240000767, Example 116::ent-2-{3-[(Cyclopropylmethoxy)methyl][1,4′-bipiperidin]-1′-yl}-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide (enantiomer 2)::US12540134, Example 116 Alpha-2C adrenergic receptor Homo sapiens 11.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643037 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643037&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370006 CC(NC(=O)c1cnc(s1)N1CCC(C(F)C1)N1CCC[C@@H](C)C1)c1cc(F)ccc1F |r| InChI=1S/C23H29F3N4OS/c1-14-4-3-8-29(12-14)20-7-9-30(13-19(20)26)23-27-11-21(32-23)22(31)28-15(2)17-10-16(24)5-6-18(17)25/h5-6,10-11,14-15,19-20H,3-4,7-9,12-13H2,1-2H3,(H,28,31) PTRXQRSHVTXSJT-UHFFFAOYSA-N 643038 US20240000767, Example 117::diamix-N-[1-(2,5-Difluorophenyl)ethyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 117 Alpha-2C adrenergic receptor Homo sapiens 0.650 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643038 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643038&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162434999 490945448 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370007 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(c(s1)C(=O)NCc1ncc(F)cc1F)-c1ccccc1Cl |r| InChI=1S/C27H30ClF2N5OS/c1-17-5-4-10-35(16-17)19-8-11-34(12-9-19)27-33-24(20-6-2-3-7-21(20)28)25(37-27)26(36)32-15-23-22(30)13-18(29)14-31-23/h2-3,6-7,13-14,17,19H,4-5,8-12,15-16H2,1H3,(H,32,36) BPBMGUATNUDFQS-UHFFFAOYSA-N 643039 US20240000767, Example 118::4-(2-Chlorophenyl)-N-[(3,5-difluoropyridin-2-yl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 118 Alpha-2C adrenergic receptor Homo sapiens 7.70 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643039 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643039&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735198 490945449 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370008 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(Br)c(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26BrF2N5OS/c1-13-3-2-6-29(12-13)15-4-7-28(8-5-15)21-27-19(22)18(31-21)20(30)26-11-17-16(24)9-14(23)10-25-17/h9-10,13,15H,2-8,11-12H2,1H3,(H,26,30) XYQVSBLNBAVPHL-UHFFFAOYSA-N 643040 US20240000767, Example 119::4-Bromo-N-[(3,5-difluoropyridin-2-yl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 119 Alpha-2C adrenergic receptor Homo sapiens 30.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643040 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643040&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735132 490945450 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370009 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(Cl)c(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26ClF2N5OS/c1-13-3-2-6-29(12-13)15-4-7-28(8-5-15)21-27-19(22)18(31-21)20(30)26-11-17-16(24)9-14(23)10-25-17/h9-10,13,15H,2-8,11-12H2,1H3,(H,26,30) IOMRPTUJPIQXAG-UHFFFAOYSA-N 643041 US20240000767, Example 120::4-Chloro-N-[(3,5-difluoropyridin-2-yl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 120 Alpha-2C adrenergic receptor Homo sapiens 41.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643041 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643041&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156734998 490945451 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370010 CCCC1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C23H31F2N5OS/c1-2-4-16-5-3-8-30(15-16)18-6-9-29(10-7-18)23-28-14-21(32-23)22(31)27-13-20-19(25)11-17(24)12-26-20/h11-12,14,16,18H,2-10,13,15H2,1H3,(H,27,31) GAAAAVSJTFUHMO-UHFFFAOYSA-N 643042 US20240000767, Example 121::rac-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3-propyl[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide::US12540134, Example 121 Alpha-2C adrenergic receptor Homo sapiens 0.650 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643042 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643042&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735214 490945452 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370011 C[C@@H]1CCCN(C1)C1CCN(CC1)c1nc(C2CC2)c(s1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C24H31F2N5OS/c1-15-3-2-8-31(14-15)18-6-9-30(10-7-18)24-29-21(16-4-5-16)22(33-24)23(32)28-13-20-19(26)11-17(25)12-27-20/h11-12,15-16,18H,2-10,13-14H2,1H3,(H,28,32) ZBXMQCZZIAFPAW-UHFFFAOYSA-N 643043 US20240000767, Example 122::4-Cyclopropyl-N-[(3,5-difluoropyridin-2-yl)methyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 122 Alpha-2C adrenergic receptor Homo sapiens 13.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643043 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643043&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735000 490945453 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370012 CCOC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C22H29F2N5O2S/c1-2-31-17-4-3-7-29(14-17)16-5-8-28(9-6-16)22-27-13-20(32-22)21(30)26-12-19-18(24)10-15(23)11-25-19/h10-11,13,16-17H,2-9,12,14H2,1H3,(H,26,30) OLYSADJEDIZFAA-UHFFFAOYSA-N 643044 US20240000767, Example 123::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3-ethoxy[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 123 Alpha-2C adrenergic receptor Homo sapiens 260 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643044&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370013 CCOC4CCCN(C3CCN(c2ncc(C(=O)NCc1ncc(F)cc1F)s2)CC3)C4 InChI=1S/C22H29F2N5O2S/c1-2-31-17-4-3-7-29(14-17)16-5-8-28(9-6-16)22-27-13-20(32-22)21(30)26-12-19-18(24)10-15(23)11-25-19/h10-11,13,16-17H,2-9,12,14H2,1H3,(H,26,30) OLYSADJEDIZFAA-UHFFFAOYSA-N 643044 US20240000767, Example 123::ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3-ethoxy[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide (enantiomer 1)::US12540134, Example 123 Alpha-2C adrenergic receptor Homo sapiens 2.90 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643044 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643044&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370014 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OCC2CCC2)c(F)c1 InChI=1S/C25H33F2N5O2S/c26-18-11-21(27)22(28-12-18)13-29-24(33)23-14-30-25(35-23)31-9-6-19(7-10-31)32-8-2-5-20(15-32)34-16-17-3-1-4-17/h11-12,14,17,19-20H,1-10,13,15-16H2,(H,29,33) JLGCDTMMQVNEKF-UHFFFAOYSA-N 50574217 CHEMBL4866383::US20240000767, Example 126::US12540134, Example 126 Alpha-2C adrenergic receptor Homo sapiens 0.490 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574217&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735188 471064362 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370015 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)OCC2CCC2)c(F)c1 InChI=1S/C25H33F2N5O2S/c26-18-11-21(27)22(28-12-18)13-29-24(33)23-14-30-25(35-23)31-9-6-19(7-10-31)32-8-2-5-20(15-32)34-16-17-3-1-4-17/h11-12,14,17,19-20H,1-10,13,15-16H2,(H,29,33) JLGCDTMMQVNEKF-UHFFFAOYSA-N 50574217 CHEMBL4866383::US20240000767, Example 126::US12540134, Example 126 Alpha-2C adrenergic receptor Homo sapiens 2.30 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574217&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735188 471064362 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370016 CCCC1CCCN(C2CCN(c3ncc(C(=O)NCc4ncc(F)cc4F)s3)CC2)C1 InChI=1S/C23H31F2N5OS/c1-2-4-16-5-3-8-30(15-16)18-6-9-29(10-7-18)23-28-14-21(32-23)22(31)27-13-20-19(25)11-17(24)12-26-20/h11-12,14,16,18H,2-10,13,15H2,1H3,(H,27,31) GAAAAVSJTFUHMO-UHFFFAOYSA-N 790472 rac-Formic acid N-[(3,5-difluoropyridin-2-yl)methyl]-2-[3-(2-fluoroethyl)[1,4'-bipiperidin]-1'-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 127 Alpha-2C adrenergic receptor Homo sapiens 8.40 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790472 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790472&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370017 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCCC2)c(F)c1 InChI=1S/C20H25F2N5OS/c21-14-10-16(22)17(23-11-14)12-24-19(28)18-13-25-20(29-18)27-8-4-15(5-9-27)26-6-2-1-3-7-26/h10-11,13,15H,1-9,12H2,(H,24,28) JZNDZDOVIMYXED-UHFFFAOYSA-N 643049 US20240000767, Example 128::2-([1,4′-Bipiperidin]-1′-yl)-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 128 Alpha-2C adrenergic receptor Homo sapiens 550 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643049 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643049&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735189 490945457 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370018 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NC1(CC1)c1ncc(F)cc1F |r| InChI=1S/C23H29F2N5OS/c1-15-3-2-8-30(14-15)17-4-9-29(10-5-17)22-27-13-19(32-22)21(31)28-23(6-7-23)20-18(25)11-16(24)12-26-20/h11-13,15,17H,2-10,14H2,1H3,(H,28,31) RPWCRNRZERJCAD-UHFFFAOYSA-N 643050 US20240000767, Example 129::N-[1-(3,5-Difluoropyridin-2-yl)cyclopropyl]-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 129 Alpha-2C adrenergic receptor Homo sapiens 10.00 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643050 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643050&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735220 490945458 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370019 CCc1nc(sc1C(=O)NCc1ncc(F)cc1F)N1CCC(CC1)N1CCC[C@@H](C)C1 |r| InChI=1S/C23H31F2N5OS/c1-3-19-21(22(31)27-13-20-18(25)11-16(24)12-26-20)32-23(28-19)29-9-6-17(7-10-29)30-8-4-5-15(2)14-30/h11-12,15,17H,3-10,13-14H2,1-2H3,(H,27,31) QONUDKILKDMADU-UHFFFAOYSA-N 643051 US20240000767, Example 130::N-[(3,5-Difluoropyridin-2-yl)methyl]-4-ethyl-2-[(3R)-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-5-carboxamide::US12540134, Example 130 Alpha-2C adrenergic receptor Homo sapiens 0.540 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643051 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643051&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735061 490945459 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370020 O=C(NCc1ncc(F)cc1F)c5cnc(N4CCC(N2CCCC3(C2)CC3(F)F)CC4)s5 InChI=1S/C22H25F4N5OS/c23-14-8-16(24)17(27-9-14)10-28-19(32)18-11-29-20(33-18)30-6-2-15(3-7-30)31-5-1-4-21(13-31)12-22(21,25)26/h8-9,11,15H,1-7,10,12-13H2,(H,28,32) GEIIJNRSUPZTGW-UHFFFAOYSA-N 643053 US20240000767, Example 132::ent-2-[4-(1,1-Difluoro-5-azaspiro[2.5]octan-5-yl)piperidin-1-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide (enantiomer 2)::US12540134, Example 132 Alpha-2C adrenergic receptor Homo sapiens 1.90 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643053&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370021 O=C(NCc1ncc(F)cc1F)c5cnc(N4CCC(N2CCCC3(C2)CC3(F)F)CC4)s5 InChI=1S/C22H25F4N5OS/c23-14-8-16(24)17(27-9-14)10-28-19(32)18-11-29-20(33-18)30-6-2-15(3-7-30)31-5-1-4-21(13-31)12-22(21,25)26/h8-9,11,15H,1-7,10,12-13H2,(H,28,32) GEIIJNRSUPZTGW-UHFFFAOYSA-N 643053 US20240000767, Example 132::ent-2-[4-(1,1-Difluoro-5-azaspiro[2.5]octan-5-yl)piperidin-1-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide (enantiomer 2)::US12540134, Example 132 Alpha-2C adrenergic receptor Homo sapiens 0.710 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643053 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643053&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370022 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)c2ccccc2)c(F)c1 InChI=1S/C26H29F2N5OS/c27-20-13-22(28)23(29-14-20)15-30-25(34)24-16-31-26(35-24)32-11-8-21(9-12-32)33-10-4-7-19(17-33)18-5-2-1-3-6-18/h1-3,5-6,13-14,16,19,21H,4,7-12,15,17H2,(H,30,34) VJPHJUDXYLAVDA-UHFFFAOYSA-N 643054 US20240000767, Example 133::rac-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-(3-phenyl[1,4′-bipiperidin]-1′-yl)-1,3-thiazole-5-carboxamide::US12540134, Example 133 Alpha-2C adrenergic receptor Homo sapiens 0.950 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643054 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643054&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735066 490945460 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370023 FC1CN(CCC1N1CCCC2(CC2(F)F)C1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C22H24F5N5OS/c23-13-6-14(24)16(28-7-13)8-29-19(33)18-9-30-20(34-18)31-5-2-17(15(25)10-31)32-4-1-3-21(12-32)11-22(21,26)27/h6-7,9,15,17H,1-5,8,10-12H2,(H,29,33) WJPCAIFTUMAFAE-UHFFFAOYSA-N 643055 US20240000767, Example 134::diamix-2-[4-(1,1-Difluoro-5-azaspiro[2.5]octan-5-yl)-3-fluoropiperidin-1-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 134 Alpha-2C adrenergic receptor Homo sapiens 0.740 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643055 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643055&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735003 490945461 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370024 FC1CN(CCC1N1CCCC2(CC2)C1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C22H26F3N5OS/c23-14-8-15(24)17(26-9-14)10-27-20(31)19-11-28-21(32-19)29-7-2-18(16(25)12-29)30-6-1-3-22(13-30)4-5-22/h8-9,11,16,18H,1-7,10,12-13H2,(H,27,31) LKPAKMYDZQMMOO-UHFFFAOYSA-N 50574218 CHEMBL4875484::US20240000767, Example 135::US12540134, Example 155 Alpha-2C adrenergic receptor Homo sapiens 0.260 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574218&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735161 471064363 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370025 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC3(COC3)C2)c(F)c1 InChI=1S/C22H27F2N5O2S/c23-15-8-17(24)18(25-9-15)10-26-20(30)19-11-27-21(32-19)28-6-2-16(3-7-28)29-5-1-4-22(12-29)13-31-14-22/h8-9,11,16H,1-7,10,12-14H2,(H,26,30) IFTYOSKCKPNDFA-UHFFFAOYSA-N 643057 US20240000767, Example 136::US12540134, Example 136 Alpha-2C adrenergic receptor Homo sapiens 320 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643057 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643057&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 166933442 490945463 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370026 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)C2CC2)c(F)c1 InChI=1S/C23H29F2N5OS/c24-17-10-19(25)20(26-11-17)12-27-22(31)21-13-28-23(32-21)29-8-5-18(6-9-29)30-7-1-2-16(14-30)15-3-4-15/h10-11,13,15-16,18H,1-9,12,14H2,(H,27,31) GBJCFYGBBFYMFQ-UHFFFAOYSA-N 643058 US20240000767, Example 137::US12540134, Example 137 Alpha-2C adrenergic receptor Homo sapiens 19.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643058 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643058&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735075 490945464 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370027 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCCC(C2)C2CCC2)c(F)c1 InChI=1S/C24H31F2N5OS/c25-18-11-20(26)21(27-12-18)13-28-23(32)22-14-29-24(33-22)30-9-6-19(7-10-30)31-8-2-5-17(15-31)16-3-1-4-16/h11-12,14,16-17,19H,1-10,13,15H2,(H,28,32) AUYDTGXOFMOOEG-UHFFFAOYSA-N 643059 US20240000767, Example 138::US12540134, Example 138 Alpha-2C adrenergic receptor Homo sapiens 6.50 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643059 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643059&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735190 490945465 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370028 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCc3ccc(Cl)cc3C2)c(F)c1 InChI=1S/C24H24ClF2N5OS/c25-17-2-1-15-3-6-32(14-16(15)9-17)19-4-7-31(8-5-19)24-30-13-22(34-24)23(33)29-12-21-20(27)10-18(26)11-28-21/h1-2,9-11,13,19H,3-8,12,14H2,(H,29,33) ZNYMEQBOVDIGIZ-UHFFFAOYSA-N 643060 US20240000767, Example 139::US12540134, Example 139 Alpha-2C adrenergic receptor Homo sapiens 0.650 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643060 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643060&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 166933409 490945466 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370029 COc1cccc2CCN(Cc12)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C25H27F2N5O2S/c1-34-22-4-2-3-16-5-8-32(15-19(16)22)18-6-9-31(10-7-18)25-30-14-23(35-25)24(33)29-13-21-20(27)11-17(26)12-28-21/h2-4,11-12,14,18H,5-10,13,15H2,1H3,(H,29,33) YBUVVPDQNUYGOE-UHFFFAOYSA-N 50574219 CHEMBL4852159::US20240000767, Example 140::US12540134, Example 140 Alpha-2C adrenergic receptor Homo sapiens 0.320 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574219 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574219&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 164617361 471064364 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370030 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCc3cccc(Cl)c3C2)c(F)c1 InChI=1S/C24H24ClF2N5OS/c25-19-3-1-2-15-4-7-32(14-18(15)19)17-5-8-31(9-6-17)24-30-13-22(34-24)23(33)29-12-21-20(27)10-16(26)11-28-21/h1-3,10-11,13,17H,4-9,12,14H2,(H,29,33) YSVFEYPKWRELJY-UHFFFAOYSA-N 643062 US20240000767, Example 141::US12540134, Example 141 Alpha-2C adrenergic receptor Homo sapiens 8.70 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643062 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643062&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 168099545 490945468 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370031 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCc3c(Cl)cccc3C2)c(F)c1 InChI=1S/C24H24ClF2N5OS/c25-19-3-1-2-15-14-32(9-6-18(15)19)17-4-7-31(8-5-17)24-30-13-22(34-24)23(33)29-12-21-20(27)10-16(26)11-28-21/h1-3,10-11,13,17H,4-9,12,14H2,(H,29,33) KTNFMERRLPTIGH-UHFFFAOYSA-N 643063 US20240000767, Example 142::US12540134, Example 142 Alpha-2C adrenergic receptor Homo sapiens 6.70 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643063 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643063&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 168099567 490945469 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370032 Cc1ccc2CCN(Cc2c1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C25H27F2N5OS/c1-16-2-3-17-4-7-32(15-18(17)10-16)20-5-8-31(9-6-20)25-30-14-23(34-25)24(33)29-13-22-21(27)11-19(26)12-28-22/h2-3,10-12,14,20H,4-9,13,15H2,1H3,(H,29,33) KYGWRYJIKUTQPQ-UHFFFAOYSA-N 50574220 CHEMBL4868807::US20240000767, Example 143::US12540134, Example 143 Alpha-2C adrenergic receptor Homo sapiens 0.420 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574220 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574220&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735204 471064365 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370033 Fc1cnc(CNC(=O)c2cnc(s2)N2CCC(CC2)N2CCc3cccc(F)c3C2)c(F)c1 InChI=1S/C24H24F3N5OS/c25-16-10-20(27)21(28-11-16)12-29-23(33)22-13-30-24(34-22)31-8-5-17(6-9-31)32-7-4-15-2-1-3-19(26)18(15)14-32/h1-3,10-11,13,17H,4-9,12,14H2,(H,29,33) HJGRRONNDXXLSC-UHFFFAOYSA-N 643065 US20240000767, Example 144::US12540134, Example 144 Alpha-2C adrenergic receptor Homo sapiens 1.80 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643065 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643065&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735018 490945471 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370034 COc1ccc2CN(CCc2c1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C25H27F2N5O2S/c1-34-20-3-2-17-15-32(7-4-16(17)10-20)19-5-8-31(9-6-19)25-30-14-23(35-25)24(33)29-13-22-21(27)11-18(26)12-28-22/h2-3,10-12,14,19H,4-9,13,15H2,1H3,(H,29,33) UFKZQBUPZWTVBU-UHFFFAOYSA-N 643066 US20240000767, Example 145::US12540134, Example 145 Alpha-2C adrenergic receptor Homo sapiens 1.000 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643066 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643066&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735090 490945472 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370035 Cc1ccc2CN(CCc2c1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C25H27F2N5OS/c1-16-2-3-18-15-32(7-4-17(18)10-16)20-5-8-31(9-6-20)25-30-14-23(34-25)24(33)29-13-22-21(27)11-19(26)12-28-22/h2-3,10-12,14,20H,4-9,13,15H2,1H3,(H,29,33) BMVVPAUGLUJCHV-UHFFFAOYSA-N 643067 US20240000767, Example 146::US12540134, Example 146 Alpha-2C adrenergic receptor Homo sapiens 1.72 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643067 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643067&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735046 490945473 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370036 COCCC1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C23H31F2N5O2S/c1-32-10-6-16-3-2-7-30(15-16)18-4-8-29(9-5-18)23-28-14-21(33-23)22(31)27-13-20-19(25)11-17(24)12-26-20/h11-12,14,16,18H,2-10,13,15H2,1H3,(H,27,31) QFBGZWGHWSKYJM-UHFFFAOYSA-N 643068 US20240000767, Example 148::US12540134, Example 148 Alpha-2C adrenergic receptor Homo sapiens 1.30 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643068 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643068&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735223 490945474 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370037 CC(C)(C)C1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C24H33F2N5OS/c1-24(2,3)16-5-4-8-31(15-16)18-6-9-30(10-7-18)23-29-14-21(33-23)22(32)28-13-20-19(26)11-17(25)12-27-20/h11-12,14,16,18H,4-10,13,15H2,1-3H3,(H,28,32) ZDMBUJWEAQBQGH-UHFFFAOYSA-N 643069 US20240000767, Example 149::US12540134, Example 149 Alpha-2C adrenergic receptor Homo sapiens 35.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643069 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643069&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 162435019 490945475 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370038 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)N(C)Cc1ncc(F)cc1F |r| InChI=1S/C22H29F2N5OS/c1-15-4-3-7-29(13-15)17-5-8-28(9-6-17)22-26-12-20(31-22)21(30)27(2)14-19-18(24)10-16(23)11-25-19/h10-12,15,17H,3-9,13-14H2,1-2H3 CHCLXTQAVVIKQC-UHFFFAOYSA-N 643070 US20240000767, Example 150::US12540134, Example 150 Alpha-2C adrenergic receptor Homo sapiens 200 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643070 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643070&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 166933432 490945476 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370039 C[C@@H]1CCCN(C1)C1CCN(CC1)c1ncc(s1)C(=O)NCc1ccccc1Cl |r| InChI=1S/C22H29ClN4OS/c1-16-5-4-10-27(15-16)18-8-11-26(12-9-18)22-25-14-20(29-22)21(28)24-13-17-6-2-3-7-19(17)23/h2-3,6-7,14,16,18H,4-5,8-13,15H2,1H3,(H,24,28) IGVWDVMNZZPWQZ-UHFFFAOYSA-N 643071 US20240000767, Example 151::US12540134, Example 151 Alpha-2C adrenergic receptor Homo sapiens 170 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643071 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643071&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 166933433 490945477 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370040 C[C@@H]1CCCN(C2CCN(c3nnc(C(=O)NCc4ncc(F)cc4F)s3)CC2)C1 InChI=1S/C20H26F2N6OS/c1-13-3-2-6-28(12-13)15-4-7-27(8-5-15)20-26-25-19(30-20)18(29)24-11-17-16(22)9-14(21)10-23-17/h9-10,13,15H,2-8,11-12H2,1H3,(H,24,29) VHXSBFDDIBVTFJ-UHFFFAOYSA-N 790496 US12540134, Example 152 Alpha-2C adrenergic receptor Homo sapiens 660 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790496 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790496&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370041 O=C(NCc1ncc(F)cc1F)c1cnc(N2CCCC(N3CCCC4(CC4)C3)CC2)s1 InChI=1S/C23H29F2N5OS/c24-16-11-18(25)19(26-12-16)13-27-21(31)20-14-28-22(32-20)29-8-1-3-17(4-10-29)30-9-2-5-23(15-30)6-7-23/h11-12,14,17H,1-10,13,15H2,(H,27,31) DUINATRYIXJBSV-UHFFFAOYSA-N 790497 rac-2-[4-(5-Azaspiro[2.5]octan-5-yl)azepan-1-yl]-N-[(3,5-difluoropyridin-2-yl)methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 153 Alpha-2C adrenergic receptor Homo sapiens 23.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790497 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790497&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370042 FC1CN(CCC1N1CCCC2(CC2)C1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C22H26F3N5OS/c23-14-8-15(24)17(26-9-14)10-27-20(31)19-11-28-21(32-19)29-7-2-18(16(25)12-29)30-6-1-3-22(13-30)4-5-22/h8-9,11,16,18H,1-7,10,12-13H2,(H,27,31) LKPAKMYDZQMMOO-UHFFFAOYSA-N 50574218 CHEMBL4875484::US20240000767, Example 135::US12540134, Example 155 Alpha-2C adrenergic receptor Homo sapiens 31.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574218&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735161 471064363 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370043 FC1CN(CCC1N1CCCC2(CC2)C1)c1ncc(s1)C(=O)NCc1ncc(F)cc1F InChI=1S/C22H26F3N5OS/c23-14-8-15(24)17(26-9-14)10-27-20(31)19-11-28-21(32-19)29-7-2-18(16(25)12-29)30-6-1-3-22(13-30)4-5-22/h8-9,11,16,18H,1-7,10,12-13H2,(H,27,31) LKPAKMYDZQMMOO-UHFFFAOYSA-N 50574218 CHEMBL4875484::US20240000767, Example 135::US12540134, Example 155 Alpha-2C adrenergic receptor Homo sapiens 2.50 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50574218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50574218&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735161 471064363 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370044 O=C(NCc1ncc(F)cc1F)c1cnc(N2CCCC(N3CCCC4(C3)CC4(F)F)CC2)s1 InChI=1S/C23H27F4N5OS/c24-15-9-17(25)18(28-10-15)11-29-20(33)19-12-30-21(34-19)31-6-1-3-16(4-8-31)32-7-2-5-22(14-32)13-23(22,26)27/h9-10,12,16H,1-8,11,13-14H2,(H,29,33) QFGNTYGTEIDRBB-UHFFFAOYSA-N 790500 diamix-2-[4-(1,1-Difluoro-5-azaspiro[2.5]octan-5-yl)azepan-1-yl]-N-[(3,5-difluoropyridin-2-yl)-methyl]-1,3-thiazole-5-carboxamide::US12540134, Example 156 Alpha-2C adrenergic receptor Homo sapiens 36.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790500 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790500&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370045 C[C@@H]1CCCN(C1)C1CCN(CC1F)c1nc(cs1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5OS/c1-13-3-2-5-28(10-13)19-4-6-29(11-16(19)24)21-27-18(12-31-21)20(30)26-9-17-15(23)7-14(22)8-25-17/h7-8,12-13,16,19H,2-6,9-11H2,1H3,(H,26,30) XAKCPRDPHQCQFB-UHFFFAOYSA-N 643032 US20240000767, Example 111::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-4-carboxamide::US12540134, Example 158 Alpha-2C adrenergic receptor Homo sapiens 2.70 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643032&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735155 490945444 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370046 C[C@@H]1CCCN(C1)C1CCN(CC1F)c1nc(cs1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5OS/c1-13-3-2-5-28(10-13)19-4-6-29(11-16(19)24)21-27-18(12-31-21)20(30)26-9-17-15(23)7-14(22)8-25-17/h7-8,12-13,16,19H,2-6,9-11H2,1H3,(H,26,30) XAKCPRDPHQCQFB-UHFFFAOYSA-N 643032 US20240000767, Example 111::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-thiazole-4-carboxamide::US12540134, Example 158 Alpha-2C adrenergic receptor Homo sapiens 98.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643032 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643032&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735155 490945444 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370047 C[C@@H]1CCCN(C1)C1CCN(CC1F)c1nc(co1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5O2/c1-13-3-2-5-28(10-13)19-4-6-29(11-16(19)24)21-27-18(12-31-21)20(30)26-9-17-15(23)7-14(22)8-25-17/h7-8,12-13,16,19H,2-6,9-11H2,1H3,(H,26,30) IOJRZQDGTDXSAE-UHFFFAOYSA-N 643033 US20240000767, Example 112::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-oxazole-4-carboxamide::US12540134, Example 160 Alpha-2C adrenergic receptor Homo sapiens 25.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643033&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735087 490945445 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370048 C[C@@H]1CCCN(C1)C1CCN(CC1F)c1nc(co1)C(=O)NCc1ncc(F)cc1F |r| InChI=1S/C21H26F3N5O2/c1-13-3-2-5-28(10-13)19-4-6-29(11-16(19)24)21-27-18(12-31-21)20(30)26-9-17-15(23)7-14(22)8-25-17/h7-8,12-13,16,19H,2-6,9-11H2,1H3,(H,26,30) IOJRZQDGTDXSAE-UHFFFAOYSA-N 643033 US20240000767, Example 112::diamix-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-3′-fluoro-3-methyl[1,4′-bipiperidin]-1′-yl]-1,3-oxazole-4-carboxamide::US12540134, Example 160 Alpha-2C adrenergic receptor Homo sapiens 435 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=643033 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=643033&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 156735087 490945445 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370049 CC1CC(N2CCC[C@@H](C)C2)CCN1c1ncc(C(=O)NCc2ncc(F)cc2F)s1 InChI=1S/C22H29F2N5OS/c1-14-4-3-6-28(13-14)17-5-7-29(15(2)8-17)22-27-12-20(31-22)21(30)26-11-19-18(24)9-16(23)10-25-19/h9-10,12,14-15,17H,3-8,11,13H2,1-2H3,(H,26,30) IPKRZCZMSYZMSV-UHFFFAOYSA-N 790505 ent-N-[(3,5-Difluoropyridin-2-yl)methyl]-2-[(3R)-2',3-dimethyl[1,4'-bipiperidin]-1'-yl]-1,3-thiazole-5-carboxamide (Diastereomer 1)::US12540134, Example 161 Alpha-2C adrenergic receptor Homo sapiens 233 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790505 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790505&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370050 CCC1CN(c2ncc(C(=O)NCc3ncc(F)cc3F)s2)CCC1N1CCC[C@@H](C)C1 InChI=1S/C23H31F2N5OS/c1-3-16-14-30(8-6-20(16)29-7-4-5-15(2)13-29)23-28-12-21(32-23)22(31)27-11-19-18(25)9-17(24)10-26-19/h9-10,12,15-16,20H,3-8,11,13-14H2,1-2H3,(H,27,31) WAEPTLYJTLTNJD-UHFFFAOYSA-N 790506 US12540134, Example 162 Alpha-2C adrenergic receptor Homo sapiens 810 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790506 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790506&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370051 CCC1CN(c2ncc(C(=O)NCc3ncc(F)cc3F)s2)CCC1N1CCC[C@@H](C)C1 InChI=1S/C23H31F2N5OS/c1-3-16-14-30(8-6-20(16)29-7-4-5-15(2)13-29)23-28-12-21(32-23)22(31)27-11-19-18(25)9-17(24)10-26-19/h9-10,12,15-16,20H,3-8,11,13-14H2,1-2H3,(H,27,31) WAEPTLYJTLTNJD-UHFFFAOYSA-N 790507 US12540134, Example 163 Alpha-2C adrenergic receptor Homo sapiens 480 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790507 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790507&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370052 CC1CN(c2ncc(C(=O)NCc3ncc(F)cc3F)s2)CCC1N1CCC[C@@H](C)C1 InChI=1S/C22H29F2N5OS/c1-14-4-3-6-28(12-14)19-5-7-29(13-15(19)2)22-27-11-20(31-22)21(30)26-10-18-17(24)8-16(23)9-25-18/h8-9,11,14-15,19H,3-7,10,12-13H2,1-2H3,(H,26,30) CMENPOHGGDFBQR-UHFFFAOYSA-N 790508 US12540134, Example 164 Alpha-2C adrenergic receptor Homo sapiens 24.0 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790508 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790508&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49 370053 CC1CN(c2ncc(C(=O)NCc3ncc(F)cc3F)s2)CCC1N1CCC[C@@H](C)C1 InChI=1S/C22H29F2N5OS/c1-14-4-3-6-28(12-14)19-5-7-29(13-15(19)2)22-27-11-20(31-22)21(30)26-10-18-17(24)8-16(23)9-25-18/h8-9,11,14-15,19H,3-7,10,12-13H2,1-2H3,(H,26,30) CMENPOHGGDFBQR-UHFFFAOYSA-N 790509 US12540134, Example 165 Alpha-2C adrenergic receptor Homo sapiens 410 US Patent 10.7270/Q25Q51XT aid1802305 US12540134 Delbeck, M; Hahn, M; Muller, T; Dietz, L; Platzk, M; Meibom, D; Buchgraber, P; Lindner, N; Becker-Pelster, EM; Schmeck, C 2/3/2026 6/15/2026 Bayer Aktiengesellschaft http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=790509 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=9126&target=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=790509&enzyme=Alpha-2C+adrenergic+receptor&column=ki&startPg=0&Increment=50&submit=Search 1 MASPALAAALAVAAAAGPNASGAGERGSGGVANASGASWGPPRGQYSAGAVAGLAAVVGFLIVFTVVGNVLVVIAVLTSRALRAPQNLFLVSLASADILVATLVMPFSLANELMAYWYFGQVWCGVYLALDVLFCTSSIVHLCAISLDRYWSVTQAVEYNLKRTPRRVKATIVAVWLISAVISFPPLVSLYRQPDGAAYPQCGLNDETWYILSSCIGSFFAPCLIMGLVYARIYRVAKLRTRTLSEKRAPVGPDGASPTTENGLGAAAGAGENGHCAPPPADVEPDESSAAAERRRRRGALRRGGRRRAGAEGGAGGADGQGAGPGAAESGALTASRSPGPGGRLSRASSRSVEFFLSRRRRARSSVCRRKVAQAREKRFTFVLAVVMGVFVLCWFPFFFSYSLYGICREACQVPGPLFKFFFWIGYCNSSLNPVIYTVFNQDFRRSFKHILFRRRRRGFRQ Alpha-2C adrenergic receptor ADA2C_HUMAN P18825 P35369 Q9HB49